SCHEDULE INFORMATION

PRINTABLE SCHEDULE (5-9-18)

  • SCHEDULES

    • SCHEDULE OVERVIEW

      Subject to Change
      Posted 4/19/18

      START TIME

      END TIME

      EVENT

      LOCATION

      TUESDAY, June 26

      4:00 PM

      11:00 PM

      UHMS Board of Directors Meeting (Private Meeting)

      Sierra 2

      WEDNESDAY, June 27

      8:00 AM

      5:00 PM

      Pre-Course: How to Prepare for Accreditation

      Fiesta 4

      8:00 AM

      5:30 PM

      Pre-Course: Mapping a course through the Reimbursement Quagmire

      Yucatan 3

      8:30 AM

      5:35 PM

      Pre-Course: Differential Diagnosis of Decompression Illness

      Yucatan 1 – 2

      1:00 PM

      4:00 PM

      ABPM Exam

      Fiesta 1

      1:00 PM

      3:00 PM

      CHT/CHRN Study Hall

      Fiesta 3

      3:30 PM

      5:30 PM

      CHT/CHRN Exam

      Fiesta 3

      3:00 PM

      5:00 PM

      Editorial Board Meeting

      Fiesta 2

      4:45 PM

      7:45 PM

      HBO Therapy Committee Meeting

      Fiesta 1

      5:30 PM

      7:30 PM

      Associate's Council Meeting

      Fiesta 2

      7:00 PM

      9:00 PM

      WELCOME RECEPTION

      Casita Courtyard

      THURSDAY, June 28

      7:00 AM

      8:00 AM

      CONTINENTAL BREAKFAST / EXHIBITS

      Fiesta 6

      7:00 AM

      8:00 AM

      Safety Committee Meeting

      Fiesta 2

      8:00 AM

      8:30 AM

      President's Address: Enoch Huang, MD

      Fiesta 5

      8:30 AM

      12:00 PM

      Non-Physician Breakout
      (not approved for physician CME credits)

      Yucatan 1-3

      8:30 AM

      10:00 AM

      Plenary Session: Hyperbaric Medicine and Cancer

      Fiesta 5

      8:30-9:15

      The role of hyperbaric medicine in cancer therapy
      John Feldmeier, DO 

      9:15-10:00


      Hyperbaric Oxygen Radiation Sensitization of Squamous Cell Carcinomas of the Oropharynx
      Dick Clarke, CHT

      10:00 AM

      10:30 AM

      BREAK / EXHIBITS

      Fiesta 6

      10:00 AM

      12:00 AM

      Specialty ED & QUARC Team Meeting (Marc Robins)

      Fiesta 1

      10:00 AM

      12:00 PM

      Accreditation Council Meeting

      Fiesta 2

      10:00 AM

      11:00 AM

      ACEP UHM Section Meeting

      Fiesta 3

      10:30 AM

      11:30 AM

      Session A: Diving / Decompression Illness: Theory & Mechanisms

      Fiesta 5

      11:00 AM

      12:00 PM

      GME Committee Meeting

      Fiesta 3

      11:30 AM

      12:00 PM

      Poster Session A

      Fiesta 7-10

      12:00 PM

      1:00 PM

      LUNCH

      ON OWN 

      12:00 PM

      1:00 PM

      Associate's Luncheon (sign up required - limited to 50)

      Durango 2

      1:00 PM

       

      2:00 PM

       

      Lambertsen Keynote: A long shot to a short shot: Hyperbaric Oxygen augmented ACLS/ATLS spawned by commercial diving medicine experience"
      Keith Van Meter, MD

      Fiesta 5

       

      2:00 PM

      5:00 PM

      Non-Physician Breakout

      Yucatan 1-3

      2:00 PM

      3:00 PM

      Session B: HBO2 Therapy Mechanisms

      Fiesta 5

      2:00 PM

      3:30 PM

      Material Testing Advisory (AD HOC) Committee

      Fiesta 1

      3:00 PM

      3:30 PM

      BREAK / EXHIBITS

      Fiesta 6

      3:30 PM

      4:00 PM

      Poster Session B

      Fiesta 7-10

      4:00 PM

      5:00 PM

      Plenary Session:  Mechanisms of HBO

      Fiesta 5

         

      Cell signaling and mechanisms of action: how does hyperbaric oxygen really work?  
      Stephen Thom, MD

       

      5:00 PM

      6:00 PM

      Education Committee Meeting

      Fiesta 1

      5:00 PM

      6:00 PM

      BNA Board Meeting

      Fiesta 3

      6:00 PM

      7:00 PM

      Exhibitor Wine & Cheese Reception

      Fiesta 6

      FRIDAY, June 29

      7:00 AM

      8:00 AM

      CONTINENTAL BREAKFAST / EXHIBITS

      Fiesta 6

      7:00 AM

      8:00 AM

      Past President’s Breakfast

      Fiesta 3

      7:00 AM

      8:00 AM

      NBDHMT Breakfast

      Fiesta 2

      8:00 AM

      12:00 PM

      NBDHMT Board Meeting

      Fiesta 1

      8:00 AM

      10:00 AM

      Plenary Session: Research and Registries for Hyperbaric Oxygen Therapy

      Fiesta 5

      8:00-8:30


      The Hyperbaric Oxygen Therapy Registry and the role of a Qualified Clinical Data Registry in protecting reimbursement
      Caroline Fife, MD 

      8:30-9:00

      The hyperbaric medicine registry at Dartmouth
      Jay Buckey, MD 

      9:00-9:30

      The role of registries in medicine
      Judith Rees, MD, PhD

      9:30-10:00

      PANEL Discussion

      10:00 AM

      10:30 AM

      BREAK / EXHIBITS

      Fiesta 6

      10:30 AM

      11:30 AM

      Session C: Diving and Decompression Illness

      Fiesta 5

      10:00 AM

      11:00 AM

      ECCHO Working Group Meeting

      Fiesta 2

      10:00 AM

      11:00 AM

      Publication Committee Meeting

      Fiesta 3

      11:00 AM

      1:00 PM

      ACHM-UHMS Meeting

      Fiesta 2

      11:30 AM

      12:30 PM

      Poster Session C

      Fiesta 7-10

      11:30 AM

      12:30 AM

      Registry Meeting (Buckey)

      Fiesta 3

      12:00 PM

      1:00 PM

      LUNCH

      ON OWN 

      1:00 PM


      2:00 PM


      Kindwall Keynote: HBOT and Diabetic Foot Ulcers: Do We Have a Leg To Stand On”
      Eugene Worth, MD

      Fiesta 5


      2:00 PM

      3:00 PM

      QUARC Committee Meeting

      Fiesta 2

      2:00 PM

      3:00 PM

      Session D: Diving and Decompression Illness

      Fiesta 5

      3:00 PM

      3:30 PM

      BREAK / EXHIBITS

      Fiesta 6

      3:00 PM

      4:00 PM

      BNA General Meeting

      Fiesta 1

      3:00 PM

      4:00 PM

      Research Committee Meeting

      Fiesta 2

      3:30 PM

      4:30 PM

      Poster Session D

      Fiesta 7-10

      4:30 PM

      5:30 PM

      Plenary Session: HBO and DFU

      Fiesta 5

      4:30-5:00


      The effectiveness and costs of hyperbaric oxygen therapy for diabetic ischemic ulcers: results of the DAMOCLES multicenter trial
      Dirk Ubbink, MD 

      5:00-5:30


      The Long Beach Wound Score as a Validated Tool for Comparative Effectiveness Research of Wounds and Objectifying the Indications for Hyperbaric Oxygen
      Michael Strauss, MD 

      5:30 PM

      6:30 PM

      UHMS Business Meeting - Open meeting

      Fiesta 5

      5:30 PM

      7:30 PM

      Specialty Council Meeting (Toups) PRIVATE Meeting

      Fiesta 1

      SATURDAY, June 30

      7:00 AM

      8:00 AM

      CONTINENTAL BREAKFAST / EXHIBITS

      Fiesta 6

      8:00 AM

      10:00 AM

      Plenary Session: Emerging Indications for Hyperbaric Oxygen Therapy

      Fiesta 5

      8:00-8:30


      Hyperbaric Oxygen Therapy for Aseptic Necrosis of the Femoral Head and of the Femoral Condyli
      Enrico Camporesi, MD 

      8:30-9:00

      Hyperbaric pre-conditioning
      Gerardo Bosco, MD 

      9:00-9:30

      Brain injury
      Shai Efrati, MD 

      9:30-10:00

      PANEL Discussion

      10:00 AM

      10:30 AM

      BREAK / EXHIBITS

      Fiesta 6

      10:30 AM

      11:30 AM

      Session E: HBO2 Therapy, Chambers, and Equipment

      Fiesta 5

      11:30 AM

      12:00 PM

      Poster Session E

      Fiesta 5

      10:00 AM

      11:00 PM

      Chapter President's Committee Meeting

      Fiesta 1

      10:00 AM

      12:00 PM

      Diving Committee Meeting

      Fiesta 3

      11:00 AM

      12:00 PM

      Membership Committee Meeting

      Fiesta 1

      12:00 PM

      1:00 PM

      LUNCH

       

      1:00 PM

      2:00 PM

      Plenary Session: New Pearls of Wisdom in the Diving and Hyperbaric Medicine Literature

      Fiesta 5

      1:00-1:30

      Diving medicine literature update
      Brian Keuski, MD; Fellow, Duke Hyperbarics

      1:30-2:00

      Hyperbaric medicine literature update
      Lince Varughese, MD; Fellow, LSU Hyperbarics

      2:00 PM

      3:00 PM

      Session F: Top Case Reports

      Fiesta 5

      3:00 PM

      3:30 PM

      BREAK / EXHIBITS

      Fiesta 6

      3:30 PM

      4:00 PM

      Poster Session F

      Fiesta 7-10

      4:00 PM

      5:00 PM

      Plenary Session: Clinical and Metabolic Aspects in Breath-hold Diving

      Fiesta 5

      4:00-4:20

      Adaptive mechanisms in breath-hold divers
      Gerardo Bosco, MD 

      4:20-4:40

      Pulmonary pathophysiology in deep breath-hold diving
      Peter Lindholm, MD 

      4:40-5:00

      Breaking news on breath-hold diving research
      Alessandro Marroni, MD

      7:00 PM

      10:00 PM

      Awards Banquet (separate fee)

      Fiesta 5

      10:00 PM

      12:00 AM

      After Party (separate fee)

      Monterrey &
      La Mesa Patio

       

       

       

       

       

       

      Read more

    • GENERAL SESSION SCHEDULE

      THURSDAY, JUNE 28 - SATURDAY, JUNE 30
      PDF copy
      Subject to change
      Posted 4/24/2018

      START TIME

      END TIME

      EVENT

      LOCATION

      THURSDAY, June 28

      7:00 AM

      8:00 AM

      CONTINENTAL BREAKFAST / EXHIBITS

      Fiesta 6

      8:00 AM

      8:30 AM

      President's Address: Enoch Huang, MD

      Fiesta 5

      8:30 AM

      12:00 PM

      Non-Physician Breakout
      (not approved for physician CME credits)

      Yucatan 1-3

      8:30 AM

      10:00 AM

      Plenary Session: Hyperbaric Medicine and Cancer

      Fiesta 5

      8:30-9:15

      The role of hyperbaric medicine in cancer therapy
      John Feldmeier, DO 

      9:15-10:00


      Hyperbaric Oxygen Radiation Sensitization of Squamous Cell Carcinomas of the Oropharynx
      Dick Clarke, CHT

      10:00 AM

      10:30 AM

      BREAK / EXHIBITS

      Fiesta 6

      10:30 AM

      11:30 AM

      Session A: Diving / Decompression Illness: Theory & Mechanisms

      Fiesta 5

      11:30-11:45



      A 1: Heliox in-water decompression schedules for the interspiro is-mix mine clearance diving system
      Bouak F, van Ooij PJ, Nishi R, van Hulst RA
      Presenting Author: Pieter-Jan van Ooij, PHD

      10:45 - 11:00



      A 2: Provocative decompression causes diffuse vascular injury mediated by interleukin (IL)-1β and inhibited by hyperbaric oxygen (HBO2).
      Thom SR, Bhopale VM, Yang M
      Presenting Author: Stephen R Thom, MD

      11:00 - 11:15



      A 3: The Effect of Intermittent Normobaric Hyperoxia on Stem Cell Mobilization and Cytokine Expression
      MacLaughlin KJ, Barton G, Braun R, Sobakin A, Eldridge M
      Presenting Author: Kent MacLaughlin

      11:15 - 11:30




      A 4: Pharmacological vasodilation and gas switching to carbon tetrafluoride during decompression to attenuate DCS
      Weis TW, Wilbur JC, Knaus DA, Buckley JC, Vann RD, Sevick JR, Stump DA, Deal DD, Ramsey M, Natoli MJ, Fellows A, MArshall C, Magari PJ, Cooter M, Moon RE
      Presenting Author: Trevor Weis

      11:30 AM

      12:00 PM

      Poster Session A

      Fiesta 7-10

       

      A 1: Heliox in-water decompression schedules for the interspiro is-mix mine clearance diving system
      Bouak F, van Ooij PJ, Nishi R, van Hulst RA
      Presenting Author: Pieter-Jan van Ooij, PHD

      A 2:
      Provocative decompression causes diffuse vascular injury mediated by interleukin (IL)-1β and inhibited by hyperbaric oxygen (HBO2).
      Thom SR, Bhopale VM, Yang M
      Presenting Author: Stephen R Thom, MD

      A 3:
      The effect of intermittent normobaric hyperoxia on stem cell mobilization and cytokine expression
      MacLaughlin KJ, Barton G, Braun R, Sobakin A, Eldridge M
      Presenting Author: Kent MacLaughlin 

      A 4: Pharmacological vasodilation and gas switching to carbon tetrafluoride during decompression to attenuate DCS
      Weis TW, Wilbur JC, Knaus DA, Buckley JC, Vann RD, Sevick JR, Stump DA, Deal DD, Ramsey M, Natoli MJ, Fellows A, MArshall C, Magari PJ, Cooter M, Moon RE
      Presenting Author: Trevor Weis

      A 5:
      Oxygen pre-breathe and decompression sickness outcomes in the uw sheep model
      Sobakin AS, Eldridge MW
      Presenting Author: Aleksey Sobakin, PHD

      A 6:
      Microparticle and interleukin (IL)-1β production associated with human high pressure exposures
      Brett KD, Nugent NZ, Fraser KN, Bhopale VM, Yang M, Thom SR
      Presenting Author: Kaighley Brett, MD

      A 7: Hyperbaric and high-oxygen environments accelerate muscle strength recovery in contused rat skeletal muscle
      Naoki Yamamoto
      Presenting Author: Naoki Yamamoto, MD

      A 8:
      Effects of a hyperbaric environment on antioxidative mechanisms in the mouse.
      Masaki H, Akira K, Naoki Y, Toshihiro K, Kazuyoshi Y
      Presenting Author: Masaki Horie, PHD

      A 9: Consistency of venous gas emboli status after three controlled pool diving exposures: a pilot study
      Denoble PJ, Papadopoulou V, Buzzacott P, Edelson CJ, Pieri M, Cialoni D, Lambrechts K, Balestra C, Marroni A
      Presenting Author: Petar Denoble, MD

      A 10: Augmentation of event related brain activity on cognitive control under hyperbaric environment
      Fujii T
      Presenting Author: Tatsufumi Fujii

      A 11:
      Effect of rehydration schedule after four-hour head out water immersion on running performance and recovery
      Stansbery RL, Hess HW, Schlader ZJ, Pendergast DR, Russo LN, Hostler D
      Presenting Author: Rebeccah Stansbery

      A 12: Cold water submersion attenuates post-submersion aerobic performance irrespective of rehydration strategy
      Hess HH, Schlader ZJ, Russo LN, Clemency BM, Stooks JJ, Carden CR, Hostler D
      Presenting Author: Hayden W Hess 

      A 13: Adapting contrast-enhanced imaging techniques to improve quantification of decompression bubbles in humans
      Hensel JSE, Le DQ, Balestra C, Tang M-X, Dayton PA, Papadopoulou V
      Presenting Author: James S. E. Hensel 

      A 14: Orthostatic intolerance following cold seawater submersion is likely independent of changes in body fluid status
      Hess H, Russo LN, Clemency BM, Stooks J, Carden C, Hostler D
      Presenting Author: Zachary J. Schlader, PHD

      A 15: Quantifying pathologic changes in the heart and lung of swine due to “yo-yo” and square dive protocols
      Ofir D, Arieli Y, Mullokandov M, Liboff A, Yanir Y
      Presenting Author: Dror Ofir, PHD

      12:00 PM

      1:00 PM

      LUNCH

      ON OWN 

      12:00 PM

      1:00 PM

      Associate's Luncheon (sign up required - limited to 50)

      Durango 2

      1:00 PM

      2:00 PM

      Lambertsen Memorial Keynote:

      Fiesta 5

       

      A long shot to a short shot: Hyperbaric Oxygen augmented ACLS/ATLS spawned by commercial diving medicine experience"
      Keith Van Meter, MD

      2:00 PM

      5:00 PM

      Non-Physician Breakout

      Yucatan 1-3

      2:00 PM

      3:00 PM

      Session B: HBO2 Therapy Mechanisms

      Fiesta 5

      2:00 - 2:15

       

       

      B 1: Oxygen microbubbles relieve tumor hypoxia and improve radiotherapy tumor control in a rat fibrosarcoma model
      Fix SM, Papadopoulou V, Velds H, Slagle C, Kasoji SK, Rivera JN, Borden MA, Chang S, Dayton PA
      Presenting Author: Samantha M. Fix

      2:15 - 2:30

      B 2: A hyperbaric and high-oxygen environment accelerates IL-6 synthesis, activates the IL-6/STAT3 pathway and suppress NFκB in rat contused skeletal muscle
      Oyaizu T, Enomoto M, Horie M, Yamamoto N, Yagishita K
      Presenting Author: Takuya Oyaizu, MD

      2:30 - 2:45




      B 3: Anti-inflammatory ability of Hyperbaric Oxygen Therapy (HBO-T) in patients with osteonecrosis
      Bosco G, Vezzani G, Rizzato A, Malacrida S, Abou-samra A, Mrakic-Sposta S, Enten G, Camporesi E
      Presenting Author: Gerardo Bosco, MD

      2:45 - 3:00



      B 4: Effects of high-intensity interval training while in a hyperbaric oxygen environment on exercise performance
      DeCato TW, Wilson EL, Weaver LK, Hegewald MJ
      Presenting Author: Matthew Hegewald, MD

      3:00 PM

      3:30 PM

      BREAK / EXHIBITS

      Fiesta 6

      3:30 PM

      4:00 PM

      Poster Session B

      Fiesta 7-10

       

      B 1: Oxygen microbubbles relieve tumor hypoxia and improve radiotherapy tumor control in a rat fibrosarcoma model
      Fix SM, Papadopoulou V, Velds H, Slagle C, Kasoji SK, Rivera JN, Borden MA, Chang S, Dayton PA
      Presenting Author: Samantha M. Fix

      B 2: A hyperbaric and high-oxygen environment accelerates IL-6 synthesis, activates the IL-6/STAT3 pathway and suppress NFκB in rat contused skeletal muscle.
      Oyaizu T, Enomoto M, Horie M, Yamamoto N, Yagishita K
      Presenting Author: Takuya Oyaizu, MD

      B 3:
      Anti-inflammatory ability of Hyperbaric Oxygen Therapy (HBO-T) in patients with osteonecrosis
      Bosco G, Vezzani G, Rizzato A, Malacrida S, Abou-samra A, Mrakic-Sposta S, Enten G, Camporesi E
      Presenting Author: Gerardo Bosco, MD

      B 4:
      Effects of high-intensity interval training while in a hyperbaric oxygen environment on exercise performance
      DeCato TW, Wilson EL, Weaver LK, Hegewald MJ
      Presenting Author: Matthew Hegewald, MD

      B 5: Aseptic Condylar Necrosis and hyperbaric oxygen therapy
      Enten G, Bosco G, Vezzani G, Manelli D, Rao N, Mangar D, Bernasek T, Camporesi E
      Presenting Author: Enrico M. Camporesi, MD

      B 6: Hyperbaric oxygen therapy ameliorates osteonecrosis in patients by modulating inflammation and oxidative stress
      Camporesi E, Enten G, Vezzani G, Rizzato A,  Bosco G
      Presenting Author: Enrico M. Camporesi, MD

      B 7: HBO2 attenuates burn induced neuropathic pain
      Wu SH
      Presenting Author: Sheng Hua Wu, MD

      B 8: Hyperbaric oxygen therapy for compromised flaps: Is there a role for delayed treatment?
      Francis A, Goldman JJ, Kleban SR, McNicoll CF, Mehta A, Phalke N, Doyle G, Nakhaima S, Rovig J, Williams SJ, Cross CL, Fang XH, Wang WZ, Baynosa RC
      Presenting Author: Ashish Francis, MD

      B 9: Ketosis as a neuroprotective mechanism to CNS Oxygen Toxicity (CNSOT) in divers exposed to high partial pressures of oxygen (PO2)
      Dituri J, Renaldo C, Quirk B, D’Agostino D, Ari C, Annis H, Whelan HT
      Presenting Author: Harry T. Whelan, MD

      B 10: Investigation of a cell-permeable mitochondrial prodrug on mitochondrial function in human blood cells from patients with CO poisoning
      Jang DH, Khatri UG, Kelly MP, Lambert DK, Hardy K
      Presenting Author: Matthew Kelly, MD

      B 11: Physiologic and cognitive effects of nutritional ketosis, elevated PO2 and exercise (KetOX Study)
      Keuski BM, Freiberger JJ, Moon RE, Richardson C, Natoli MJ, Schinazi EA, D’Agostino DP, Kuchibhatla M, Tomoye EO, Derrick BJ
      Presenting Author: Brian M. Keuski, MD

      B 12: Supraventricular Tachycardia during hyperbaric oxygen treatment
      Mihai A, Morgan M, Heyboer M
      Presenting Author: Aurel Mihai, MD

      B 13: Ketogenic diet for reduction of CNS oxygen toxicity in working divers (KetOX Study)
      Keuski BM, Freiberger JJ, Moon RE, Richardson C, Natoli MJ, Schinazi EA, D’Agostino DP, Kuchibhatla M, Tomoye EO, Derrick BJ
      Presenting Author: Brian Keuski, MD

      4:00 PM

      5:00 PM

      Plenary Session:  Mechanisms of HBO2

      Fiesta 5

         

      Cell signaling and mechanisms of action: how does hyperbaric oxygen really work? 
      Stephen Thom, MD

       

      6:00 PM

      7:00 PM

      Exhibitor Wine & Cheese Reception

      Fiesta 6

      FRIDAY, June 29

      7:00 AM

      8:00 AM

      CONTINENTAL BREAKFAST / EXHIBITS

      Fiesta 6

      8:00 AM

      10:00 AM

      Plenary Session: Research and Registries for Hyperbaric Oxygen Therapy

      Fiesta 5

      8:00-8:30


      The Hyperbaric Oxygen Therapy Registry and the role of a Qualified Clinical Data Registry in protecting reimbursement
      Caroline Fife, MD 

      8:30-9:00

      The hyperbaric medicine registry at Dartmouth
      Jay Buckey, MD 

      9:00-9:30

      The role of registries in medicine
      Judith Rees, MD, PhD

      9:30-10:00

      PANEL Discussion

      10:00 AM

      10:30 AM

      BREAK / EXHIBITS

      Fiesta 6

      10:30 AM

      11:30 AM

      Session C: Diving and Decompression Illness

      Fiesta 5

      10:30 - 10:45


      C 1: CNS oxygen toxicity – models vs practice
      Garbino A, Walker S, Sanders R
      Presenting Author: Alejandro Garbino, MD

      10:45 - 11:00



      C 3: Recreational diving related injuries among insured Divers Alert Network Japan members: Retrospective analysis of 321 cases from 2010 to 2014
      Kojima Y, Suzuki S, Niizeki Y, Kojima A, Kawaguchi H, Yagishita K
      Presenting Author: Yasushi Kojima, MD

      11:00 - 11:15


      C 4: Pulmonary fluid shifts are a common result of SCUBA diving exposures
      Sanders RW, Williams S, Ray K
      Presenting Author: Robert Sanders, MD

      11:15 - 11:30


      C 5: Analysis of 500 self-reported recreational scuba diving incidents
      Buzzacott P, Bennett CM, Denoble PJ
      Presenting Author: Peter Buzzacott, PHD

      11:30 AM

      12:00 PM

      Poster Session C

      Fiesta 7-10

       

      C 1: CNS oxygen toxicity – models vs practice
      Garbino A, Walker S, Sanders R
      Presenting Author: Alejandro Garbino, MD

      C 2: Withdrawn

      C 3: Recreational diving related injuries among insured Divers Alert Network Japan members: Retrospective analysis of 321 cases from 2010 to 2014
      Kojima Y, Suzuki S, Niizeki Y, Kojima A, Kawaguchi H, Yagishita K
      Presenting Author: Yasushi Kojima, MD

      C 4: Pulmonary fluid shifts are a common result of scuba diving exposures
      Sanders RW, Williams S, Ray K
      Presenting Author: Robert Sanders, MD

      C 5: Analysis of 500 self-reported recreational scuba diving incidents
      Buzzacott P, Bennett CM, Denoble PJ.
      Presenting Author: Peter Buzzacott, PHD

      C 6: Risk factors for middle ear barotrauma in subjects undergoing hyperbaric oxygen therapy
      Hatch JL, Wieland AM, High R, Cooper JS
      Presenting Author: Jeffrey Cooper, MD

      C 7: A Decompression stop for fishermen divers of the Yucatán Peninsula
      Chin W, Lik U, Huchim O, Markovitz G, Galovich J
      Presenting Author: Walter Chin, RN/CHRN

      C 8: Upper and lower extremity altitude chamber DCS
      Hayes, WA
      Presenting Author: William A Hayes II, DO

      C 9: Who’s listening? Ear health and diving: data from 790 divers
      St Leger Dowse M, Waterman M. Jones R, Smerdon GR.
      Presenting Author: Marguerite St Leger Dowse

      C 10: Ten year period prevalence of decompression illness among small-scale fishermen divers
      Chin W, Ramachandran M, Huchim-Lara O
      Presenting Author: Walter Chin, RN/CHRN

      C 11: Cerebrovascular Responses to Thermoneutral Head Out Water Immersion
      Schlader ZJ, Sackett JR
      Presenting Author: Blair D. Johnson, PHD

      C 12: Rater reliability of a transthoracic bubble study among fishermen divers of the Yucatán Peninsula
      Chin W, Huchim O, Endo B, Medak A, Ramachandran M, Popa D
      Presenting Author: Walter Chin, RN/CHRN

      C 13: Prevalence of Right-to-Left Shunt among Fishermen Divers of the Yucatán Peninsula
      Chin W, Huchim O, Endo B, Medak A, Ramachandran M, Popa D
      Presenting Author: Brandon Endo, MD

      C 14: Bubbles in vascular plexuses of the skin in the cutaneous decompression sickness. Report of cases
      Garcia E, Galicia P, Villanueva V.
      Presenting Author: Eduardo Garcia, MD

      C 15: Treatments of Dysbaric Osteonecrosis
      Kawashima M, Kawashima M, Tamura H, Nagayoshi I, Furue Y, Motoyama T, Sasaki T, Watanabe Y, Goto T, Takao K, Yamaguchi T, Miyata K.
      Presenting Author: Mahito Kawashima, MD

      12:00 PM

      12:30 PM

      Poster Session C

      Fiesta 7-10

       

      C 16: Perilymphatic fistula after diving: a case series
      Johnson-Arbor K
      Presenting Author: Kelly Johnson-Arbor, MD

      C 17:  Effect of single breath oxygen on breath-hold time
      Weaver AL, Weaver LK, Deru K
      Presenting Author: Anika Weaver 

      C 18: Physical disabilities after decompression illness among small-scale fishermen divers of the Yucatán Peninsula
      Aguiñaga S., Huchim-Lara O., Chin W.
      Presenting Author: Sofia Aguinaga 

      C 19: Oxygen exposures at NASA’s neutral buoyancy lab: a 20-year experience
      Walker SC, Garbino A, Ray K, Hardwick R, Fitzpatrick DT, Sanders RW
      Presenting Author: Robert Sanders, MD

      C 20: Estimated workload intensity during volunteer aquarium dives
      Buzzacott P, Grier JW, Walker J, Bennett CM, Denoble PJ
      Presenting Author: Peter Buzzacott, PHD

      C 21: Successful treatment of decompression illness complicated with acute hepatic infarction and acute kidney injury: A case report
      Oh SH, Choi SC, Cha YS, Lee YH, Kim GW, Kim H
      Presenting Author: Se Hyun Oh, MD

      C 22: Recurrent facial baroparesia: A case report
      Gomez-Castillo JD, Esquivel-Garcia B
      Presenting Author: Dario Gomez, MD

      C 23: Hyperbaric oxygen therapy for Type-II DCS in an experienced dive master – A case study
      Boes T, Morgan M, Sharma D, Santiago W, Mariani P, Heyboer M
      Presenting Author: Tanner Boes, MD

      C 24: hyperbaric oxygen therapy for type-i dcs secondary to Hypobaric Challenge – A case study
      Boes T, Morgan M, Sharma D, Santiago W, Mariani P, Heyboer M
      Presenting Author: Tanner Boes, MD

      C 25: Urinary obstruction following octopus bite
      Weaver, LK
      Presenting Author: Lindell K. Weaver, MD

      C 26: DCS with incidental pulmonary cyst
      Norton M, Weaver L, Uchida D
      Presenting Author: Mariesa N. Norton, ACNP/PA

      C 27: Unusual response to a presumptive stingray spine injury
      Do R, Lu LQ, Strauss MB
      Presenting Author: Michael B. Strauss, MD

      C 28: The impact of hyperbaric oxygen therapy on chronic Lyme disease:  A case study
      Linden RO, Zacher JE, LeDez KM, Cook T
      Presenting Author: Ron Linden, MD

      C 29:
      A pilot study evaluating knowledge of indications for hyperbaric oxygen therapy among physicians in Mid-Michigan
      Jones MW, Henning WH
      Presenting Author: Werner Henning, DO

      C 30: Underwater nasal decongestant use: A novel approach to middle ear equalization during a dive
      Covington DB, Pitkin AD
      Presenting Author: Derek Covington, MD

      12:00 PM

      1:00 PM

      LUNCH

      ON OWN 

      1:00 PM

      2:00 PM

      Kindwall Memorial Keynote:

      Fiesta 5

       

      HBOT and Diabetic Foot Ulcers: Do We Have a Leg To Stand On”
      Eugene Worth, MD

      2:00 PM

      3:00 PM

      Session D: Diving and Decompression Illness

      Fiesta 5

      2:00 - 2:15



      D 1: A randomized trial of one v. three hyperbaric oxygen sessions for acute carbon monoxide poisoning
      Weaver LK, Churchill S, Deru K, Handrahan D
      Presenting Author: Lindell K. Weaver, MD

      2:15 - 2:30






      D 2: A clinical practice guideline for the prevention and treatment of Mandibular Osteoradionecrosis (ORN) applying  GRADE methodology.
      UHMS CPG Authors: Feldmeier JJ,  DuBose KJ, Gesell LB,  Shah JB,  Huang ET, Mansouri J, Marx RE
      UHMS CPG Oversight Committee:  Feldmeier JJ, LeDez K, Le PNJ, Mansouri J, Moon R, Murad MH
      Presenting Author: John Feldmeier, DO

      2:30 - 2:45



      D 3: Sleep assessment in a randomized trial of hyperbaric oxygen in U.S. service members with post-concussive symptoms
      Walker JM, Mulatya C, Hebert D, Wilson SH, Lindblad AS, Weaver LK
      Presenting Author: Lindell K. Weaver, MD

      2:45 - 3:00


      D 4: A composite outcome for mild traumatic brain injury in trials of hyperbaric oxygen
      Weaver LK, Churchill S, Wilson SH, Hebert D, Deru K, Lindblad AS
      Presenting Author: Steffanie Wilson, PHD

      3:00 PM

      3:30 PM

      BREAK / EXHIBITS

      Fiesta 6

      3:30 PM

      4:00 PM

      Poster Session D

      Fiesta 7-10

       

      D 1: A randomized trial of one v. three hyperbaric oxygen sessions for acute carbon monoxide poisoning
      Weaver LK, Churchill S, Deru K, Handrahan D
      Presenting Author: Lindell K. Weaver, MD

      D 2: A clinical practice guideline for the prevention and treatment of Mandibular Osteoradionecrosis (ORN) applying  GRADE methodology
      UHMS CPG Authors: Feldmeier JJ,  DuBose KJ, Gesell LB,  Shah JB,  Huang ET, Mansouri J, Marx RE
      UHMS CPG Oversight Committee:  Feldmeier JJ, LeDez K, Le PNJ, Mansouri J, Moon R, Murad MH
      Presenting Author: John Feldmeier, DO

      D 3: Sleep assessment in a randomized trial of hyperbaric oxygen in U.S. service members with post-concussive symptoms
      Walker JM, Mulatya C, Hebert D, Wilson SH, Lindblad AS, Weaver LK
      Presenting Author: Lindell K. Weaver, MD

      D 4: A composite outcome for mild traumatic brain injury in trials of hyperbaric oxygen
      Weaver LK, Churchill S, Wilson SH, Hebert D, Deru K, Lindblad AS
      Presenting Author: Steffanie Wilson, PHD

      D 5: Hyperbaric oxygen therapy effect on patients suffering from fibromyalgia due to childhood sexual abuse – randomized controlled trial
      Hadanny A, Bechor Y, Catalogna M, Daphna S, Lev R, Efrati S
      Presenting Author: Amir Hadanny, MD

      D 6: Hyperbaric oxygen for TBI and PTSD: A meta-analysis of Department of Defense and other published study results
      Hart BB, Weaver LK, Gupta A, Wilson SH, Vifayarangan A, Deru K, Hebert D
      Presenting Author: Brett Hart, MD

      D 7: Hyperbaric oxygen therapy can rescue ischemic breast flaps following skin-sparing mastectomy
      Rajpal N, Walters E, Elmarsafi T, Johnson-Arbor K, Pittman T
      Presenting Author: Kelly Johnson-Arbor, MD

      D 8: A retrospective analysis of treatment of wounds caused by Calciphylaxis: Hyperbaric oxygen therapy with and without Sodium Thiosulfate
      Armour D, Tailor Y, Preston-Hsu E
      Presenting Author: Doris Armour, MD

      D 9: The effect hyperbaric oxygen on erectile dysfunction – Pilot study
      Hadanny A, Lang E, Copel L, Meir O, Bechor Y, Fishlev G, Bergan J, Zisman A, Efrati S
      Presenting Author: Amir Hadanny, MD

      D 10: Effects of hyperbaric oxygen therapy on non-diabetic serum glucose levels
      Boes T, Wojcik S, Heyboer M, Seargent S
      Presenting Author: Tanner Boes, MD

      D 11: Case series review: Multicenter experience treating Idiopathic Sudden Sensorineural Hearing Loss (ISSHL) with adjunctive hyperbaric oxygen therapy
      Robins MS, Gwilliam A, Weaver LK, Churchill S, Deru K, Cascio M, Pollack R, Nail S
      Presenting Author: Marc Robins, DO

      D 12:
      Hyperbaric oxygen treatment course completion and time to drop-out in a large outpatient sample
      Brailsford JB, Gordon HM, Ennis, WJ
      Presenting Author: Jennifer Brailsford, PHD

      D 13: Advanced wound care assessment as a pre-cursor to HBO2: Improving diabetic foot ulcer outcomes
      Tremblay R, Michael M
      Presenting Author: Roma Tremblay, PHD

      D 14: Hyperbaric oxygen therapy: A review of adverse event rates during treatment for Radiation Cystitis
      Owen E, Perdrizet G
      Presenting Author: Elizabeth Owen, MD

      D 15: Appraisal of six wound scoring systems and the Long Beach Wound Score
      Strauss MB, Moon H, Botros M, Lu LQ
      Presenting Author: Michael B. Strauss, MD

      4:00 PM

      4:30 PM

      Poster Session D

      Fiesta 7-10

       

      D 16: Spinal cord radiation injury reversed by hyperbaric oxygen therapy
      Cianci PE, Costello PJ
      Presenting Author: Paul Cianci, MD

      D 17: Adjunctive hyperbaric oxygen therapy with isavuconizonium in the treatment of Mucor
      Evangelista J
      Presenting Author: Jose Evangelista, MD

      D 18: Impact of hyperbaric oxygen therapy in a child with delayed soft tissue radiation necrosis of the brain.
      Dapena JC, Siegel M
      Presenting Author: Juan C. Dapena, MD

      D 19:
      Hyperbaric oxygen therapy for the treatment of delayed frostbite injury
      Johnson-Arbor K
      Presenting Author: Kelly Johnson-Arbor, MD

      D 20: Use of hyperbaric oxygen therapy for lower extremity sickle cell ulcerations
      Johnson-Arbor K
      Presenting Author: Kelly Johnson-Arbor, MD

      D 21: Use of hyperbaric oxygen therapy for treatment of acute skin necrosis after a “Brazilian Butt Lift”
      Johnson-Arbor K
      Presenting Author: Kelly Johnson-Arbor, MD

      D 22: Decision making for limb threatening wounds
      Strauss MB, Moon H, Miller SS, Lu LQ
      Presenting Author: Michael B. Strauss, MD

      D 23: Case report: High-throughput enterocutaneous fistula and the role of HBO2
      Borges HL, Oliveira N, Paz MA, Santos PE, Toni JP
      Presenting Author: Hugo Borges, MD

      D 24:
      Case Report: HBO2 avoiding amputation in serious osteomyelitis of ankle
      Borges HL, Oliveira N, Paz MA, Santos PE, Toni JP
      Presenting Author: Hugo Borges, MD

      D 25: Femoropopliteal doppler velocities associated with hyperbaric oxygen treatment session of diabetic patients with leg ulcers
      Maran CA, Salles-Cunha SX, Millazo PAA, Farias PSR, Castro IJL, David JRN, David RAR
      Presenting Author: Maran Cristiane Antequeira, MD

      D 26: Smoking paradox in the development of delayed neuropsychiatric sequelae among acute carbon monoxide (CO) intoxication patients with hyperbaric oxygen therapy
      Lee Y
      Presenting Author: Younghwan Lee, MD

      D 27: The historical priority of South America in hyperbaric research and practice
      Brito T, Subbotina N
      Presenting Author: Tomaz Brito, MD and Nina Subbotina, MD

      D 28: Successful artificial sphincter placement for urinary incontinence in the setting of radiation cystitis with adjunctive hyperbaric oxygen therapy – A case study
      Boes T, Morgan M, Sharma D, Santiago W, Mariani P, Heyboer M
      Presenting Author: Tanner Boes, MD

      D 29: Hyperbaric Oxygen Treatments for vasculitis induced by levamisole containing cocaine
      Ptak J, Reetz S, Buckey J
      Presenting Author: Judy Ptak, RN/CHRN

      D 30: Closing RICH-ART study:  Radiation induced cystitis treated with hyperbaric oxygen – A randomized controlled trail
      Oscarsson N, Bueller B, Seeman-Lodding H
      Presenting Author: Nicklas Oscarsson, MD

      4:30 PM

      5:30 PM

      Plenary Session: HBO and DFU

      Fiesta 5

      4:30-5:00


      The effectiveness and costs of hyperbaric oxygen therapy for diabetic ischemic ulcers: results of the DAMOCLES multicenter trial
      Dirk Ubbink, MD 

      5:00-5:30


      The Long Beach Wound Score as a Validated Tool for Comparative Effectiveness Research of Wounds and Objectifying the Indications for Hyperbaric Oxygen
      Michael Strauss, MD 

      5:30 PM

      6:30 PM

      UHMS Business Meeting - Open meeting

      Fiesta 5

      SATURDAY, June 30

      7:00 AM

      8:00 AM

      CONTINENTAL BREAKFAST / EXHIBITS

      Fiesta 6

      8:00 AM

      10:00 AM

      Plenary Session: Emerging Indications for Hyperbaric Oxygen Therapy

      Fiesta 5

      8:00-8:30


      Hyperbaric Oxygen Therapy for Aseptic Necrosis of the Femoral Head and of the Femoral Condyli
      Enrico Camporesi, MD 

      8:30-9:00

      Hyperbaric pre-conditioning
      Gerardo Bosco, MD 

      9:00-9:30

      Brain injury
      Shai Efrati, MD 

      9:30-10:00

      PANEL Discussion

      10:00 AM

      10:30 AM

      BREAK / EXHIBITS

      Fiesta 6

      10:30 AM

      11:30 AM

      Session E: HBO2 Therapy, Chambers, and Equipment

      Fiesta 5

      10:30-10:45



      E 1: Preprogramed bailout and surface decompression schedules for multiplace treament profiles
      Raleigh GW
      Presenting Author: Greg Raleigh, CHT

      10:45-11:00


      E 2: Hyperbaric oxygen simulation education
      Arefieva CA, Duchnick J, Bermudez R, Witucki P, Shishlov K, Sadler C
      Presenting Author: Christa Arefieva

      11:00-11:15



      E 3: Performance characteristics of high frequency percussive ventilation (HFPV) under hyperbaric conditions
      Huang ET, Heltborg JL, Apsey RT, Ray K
      Presenting Author: Kristi Ray, MD

      11:15-11:30



      E 4: Observations on O2% during air breathing periods using a non-rebreather face mask in a monoplace chamber
      Bell J , Koumandakis G, Churchill S , Weaver LK
      Presenting Author: James Bell, CHT

      11:30 AM

      12:00 PM

      Poster Session E

      Fiesta 5

       

      E 1: Preprogramed bailout and surface decompression schedules for multiplace treament profiles
      Raleigh GW
      Presenting Author: Greg Raleigh, CHT

      E 2: Hyperbaric oxygen simulation education
      Arefieva CA, Duchnick J, Bermudez R, Witucki P, Shishlov K, Sadler C
      Presenting Author: Christa Arefieva, 

      E 3:
      Performance characteristics of high frequency percussive ventilation (HFPV) under hyperbaric conditions
      Huang ET, Heltborg JL, Apsey RT, Ray K
      Presenting Author: Kristi Ray, MD

      E 4: Observations on O2% during air breathing periods using a non-rebreather face mask in a monoplace chamber
      Bell J , Koumandakis G, Churchill S , Weaver LK
      Presenting Author: James Bell, CHT

      E 5: Interim analysis of mucosal atomizer use to maintain myringotomy patency during elective hyperbaric treatments
      Walter J, Westgard B, Hendriksen S, Masters T, Logue C
      Presenting Author: Joe Walter, MD

      E 6:
      Intellivue MP30
      Bliss C, Mosteller J
      Presenting Author: Chae Bliss, CHT

      E 7:
      Leg ulcer characterization by photographic imaging pre and post hyperbaric oxygen treatment: Lessons learned with first 10 cases
      Maran CA, Salles-Cunha SX, Millazo PAA, Farias PSR, Castro IJL, David JRN, David RAR
      Presenting Author: Maran Cristiane Antequeira, MD

      E 8: Responding to an active shooter – Learning from one facility’s experience
      Ptak J, Cormier J
      Presenting Author: Judy Ptak, RN/CHRN

      E 9: Use of High Frequency Percussive Ventilation (HFPV) in a patient with carbon monoxide poisoning
      Huang ET, Heltborg JL, Apsey RJ
      Presenting Author: Enoch Huang, MD

      E 10: continuous bladder irrigation in the monoplace hyperbaric chamber: A cautionary tale
      Cooper JS, Lagrange CA
      Presenting Author: Jeffrey Cooper, MD

      E 11: The use of indocyanine green fluorescence angiography to assess perfusion of chronic wounds undergoing hyperbaric oxygen therapy
      Kim DU, Rao A, Kaplan S, Baksh F, Caprioli R,  Haight J, Ferguson RG, Pliskin M, Oropallo A
      Presenting Author: Alisha Oropallo, MD

      E 12: Utilization of fluorescence microangiography (LUNA) in a pediatric patient with acute compartment syndrome
      Walter J, Settypalli S, Westgard B, Hendriksen S, Masters T, Logue C
      Presenting Author: Joe Walter, MD

      E 13: Public awareness of carbon monoxide poisoning
      Gwilliam AM, Williams B, Stewart JR, Robins MS
      Presenting Author: Annette Gwilliam, RN/CHRN

      E 14:
      Surviving an active shooter event
      Brown P
      Presenting Author: Paul Brown, CHT

      12:00 PM

      1:00 PM

      LUNCH

       

      1:00 PM

      2:00 PM

      Plenary Session: New Pearls of Wisdom in the Diving and Hyperbaric Medicine Literature

      Fiesta 5

      1:00-1:30

      Diving medicine literature update
      Brian Keuski, MD; Fellow, Duke Hyperbarics

      1:30-2:00

      Hyperbaric medicine literature update
      Lince Varughese, MD; Fellow, LSU Hyperbarics

      2:00 PM

      3:00 PM

      Session F: Top Case Reports

      Fiesta 5

      2:00-2:10


      F 1: Case series of central retinal artery occlusion followed with bedside ultrasound
      Hendriksen SM, Masters TC, Westgard BC, Walter JW, Logue CJ
      Presenting Author: Stephen Hendriksen, MD

      2:10-2:20



      F 2: AGE during controlled ascent training in a Navy Diver trainee: A case report with video registration of the accident
      Wingelaar TT, van Ooij PJ, Koch D
      Presenting Author: Thijs Wingelaar, MD

      2:20-2:30


      F 3: Reversal of central pontine myelinolysis symptoms with hyperbaric oxygen therapy
      Bensusan AB, Staab P, LeGros TL, Murphy-Lavoie H
      Presenting Author: Ariana P Bensusan, DO

      2:30-2:40


      F 4: Taravana: A syndrome revisited, A case report
      Derksen BD, Savaser DJ
      Presenting Author: Davut Savaser, MD

      2:40-2:50


      F 5: Acute scalp necrosis successfully treated with hyperbaric oxygen therapy
      Johnson-Arbor K
      Presenting Author: Kelly Johnson-Arbor, MD

      2:50-3:00



      F 6: Delayed hyperbaric oxygen therapy for cerebral arterial gas embolism following scuba diving: A case report.
      Brett KD, Boni B, Latham E, Sadler C
      Presenting Author: Kaighley Brett, MD

      3:00 PM

      3:30 PM

      BREAK / EXHIBITS

      Fiesta 6

      3:30 PM

      4:00 PM

      Poster Session F

      Fiesta 7-10

       

      F 1: Case series of central retinal artery occlusion followed with bedside ultrasound
      Hendriksen SM, Masters TC, Westgard BC, Walter JW, Logue CJ
      Presenting Author: Stephen Hendriksen, MD

      F 2: AGE during controlled ascent training in a Navy Diver trainee: A case report with video registration of the accident
      Wingelaar TT, van Ooij PJ, Koch D
      Presenting Author: Thijs Wingelaar, MD

      F 3: Reversal of central pontine myelinolysis symptoms with hyperbaric oxygen therapy
      Bensusan AB, Staab P, LeGros TL, Murphy-Lavoie H
      Presenting Author: Ariana P Bensusan, DO

      F 4: Taravana: A syndrome revisited, A case report
      Derksen BD, Savaser DJ
      Presenting Author: Davut Savaser, MD

      F 5:
      Acute scalp necrosis successfully treated with hyperbaric oxygen therapy
      Johnson-Arbor K
      Presenting Author: Kelly Johnson-Arbor, MD

      F 6: Delayed hyperbaric oxygen therapy for cerebral arterial gas embolism following scuba diving: A case report.
      Brett KD, Boni B, Latham E, Sadler C
      Presenting Author: Kaighley Brett, MD
       
      F 7: A case of trigeminal neuralgia treated with hyperbaric oxygen
      Huang ET
      Presenting Author: Enoch Huang, MD

      F 8: Cerebral AGE from upper endodoscopy
      Popa DA, Witucki P
      Presenting Author: Daniel Popa, MD

      F 9: Hyperbaric oxygen for late sequelae of carbon monoxide poisoning enhances neurological recovery
      Keim LW, Koneru S, Ramos V, Murr N, Hoffnung DS, Murman DL,  Cooper JS, Torres-Russotto D
      Presenting Author: Jeffrey Cooper, MD

      F 10: Facial baroparesis as a complication of HBO2: A previously unreported cause of a rare condition
      Sayers MP, Lopez E, Gutfreund Y
      Presenting Author: Martin P Sayers, MD

      F 11: Cerebral arterial gas embolism in a scuba instructor: An interesting cause
      Garcia E, Galicia P, Villanueva V
      Presenting Author: Eduardo Garcia, MD

      F 12: The role of emergent hyperbaric oxygen therapy in treatment of traumatic central retinal artery occlusion in patients after facial bone fracture
      Shu-Hung H
      Presenting Author: Huang Shu-Hung, MD

      F 13: Hypoglycemia after scuba diving with insulin pump
      Gomez-Castillo JD, Contreras U, Reyes-Silva KN
      Presenting Author: Jorge Dario Gomez Castillo, MD

      F 14: Lyme disease developing during hyperbaric oxygen treatments
      Ptak J, Reetz S, Buckey J
      Presenting Author: Judy Ptak, RN/CHRN

      F 15: Case report: The role of HBO2 in a spider bite
      Borges HL, Oliveira N, Paz MA, Santos PE, Toni JP
      Presenting Author: Hugo Borges, MD

      4:00 PM

      5:00 PM

      Plenary Session: Clinical and Metabolic Aspects in Breath-hold Diving

      Fiesta 5

      4:00-4:20

      Adaptive mechanisms in breath-hold divers
      Gerardo Bosco, MD 

      4:20-4:40

      Pulmonary pathophysiology in deep breath-hold diving
      Peter Lindholm, MD 

      4:40-5:00

      Breaking news on breath-hold diving research
      Alessandro Marroni, MD

      7:00 PM

      10:00 PM

      Awards Banquet (separate fee)

      Fiesta 5

      10:00 PM

      12:00 AM

      After Party (separate fee)

      Monterrey &
      La Mesa Patio


       

       

       

      Read more

    • PRE-COURSE SCHEDULES

      PRE-COURSES: WEDNESDAY, JUNE 27
      Coming soon

      Read more

    • NON-PHYSICIAN TRACK SCHEDULE

      THURSDAY, JUNE 28
      Posted 5-9-18 (subject to change)
      (not approved for physician CME credits)

      8:00-8:30

      President's Address

      Enoch Huang, MD in Fiesta 5

      8:30-5:00

      NON-Physician Track Kick Off

       Yucatan 1-3

      8:30-8:40 

      Welcome & Introductions

      Gus Gustavson, RN

      8:40-8:50 

      UHMS Associates Update

      Kaye Moseley, RRT

      8:50-9:00

      BNA Update

      Annette Gwilliam, ACHRN

      9:00-9:30

      A decompression stop for fishermen divers of the Yucatán Peninsula
      & Ten-year period prevalence of decompression illness among small-scale fishermen divers & Rater reliability of a transthoracic bubble study among fishermen divers of the Yucatán Peninsula

      Walter Chin

      9:30-9:45

      Effect of rehydration schedule after four-hour head-out water immersion on running performance and recovery

      Rebeccah Stansbery

      9:45-10:00

      Physical disabilities after decompression illness among small-scale fishermen divers of the Yucatán Peninsula

      Sofia Aguinaga

      10:00-10:30

      Break/Exhibits

      Break/Exhibits

      10:30-10:45 

      Preprogramed bailout and surface decompression schedules for multiplace treatment profiles

      Greg Raleigh 

      10:45-11:00 

       Effect of single-breath oxygen on breath-hold time

      Anika Weaver 

      11:00-11:15

      Achievement Recognition Scholarship Abstract:
      Multiplace hyperbaric chamber modifications for safe utilization of a non-hyperbaric rated cardiac monitor

      Chae Bliss 

      11:15-1130 

      DCS with incidental pulmonary cyst

      Mariesa N. Norton

      11:30-11:45 Public awareness of carbon monoxide poisoning Annette Gwilliam

      11:45-12:00 

      Responding to an active shooter – Learning from one facility’s experience

      Judy Ptak 

      12:00-1:00

      Associates Luncheon (registration sign-up required - limited to 50)

      Durango 2

      1:00-2:00

      Lambertsen Memorial Keynote: A long shot to a short shot: Hyperbaric oxygen augmented ACLS/ATLS spawned by commercial diving medicine experience

      Keith Van Meter, MD in Fiesta 5 

      2:00-2:45

      Risk factors for diving injuries

      Peter Buzzacott

      2:45-3:00

      Adapting contrast-enhanced imaging techniques to improve quantification of decompression bubbles in humans 

      James E. H. Hensel

      3:00-3:30

      Break

      Break

      3:30-3:45

      Surviving an active shooter

      Paul Brown

      3:45-4:00

      Who’s listening? Ear health and diving: Data from 790 divers

      Marguerite St. Leger Dowse

      4:00-4:20

      Hyperbaric oxygen treatments for vasculitis induced by levamisole containing cocaine & Lyme disease developing during hyperbaric oxygen treatments

      Judy Ptak

      4:20-5:00

       Wound healing centers and the bends

      Matias Nochetto

       

       

       

      Read more

    • ABSTRACT SCHEDULE


      THURSDAY, JUNE 28

      10:30 AM

      11:30 AM

      Session A: Diving / Decompression Illness: Theory & Mechanisms: Oral Presentations

      Fiesta 5

      10:30 - 10:45

      A 1: Heliox in-water decompression schedules for the Interspiro Is-mix mine clearance diving system
      Bouak F, van Ooij PJ, Nishi R, van Hulst RA
      Presenting Author: Pieter-Jan van Ooij, PHD

      10:45 - 11:00

      A 2: Provocative decompression causes diffuse vascular injury mediated by interleukin (IL)-1β and inhibited by hyperbaric oxygen (HBO2).
      Thom SR, Bhopale VM, Yang M
      Presenting Author: Stephen R Thom, MD

      11:00 - 11:15

      A 3: The Effect of Intermittent Normobaric Hyperoxia on Stem Cell Mobilization and Cytokine Expression
      MacLaughlin KJ, Barton G, Braun R, Sobakin A, Eldridge M
      Presenting Author: Kent MacLaughlin

      11:15 - 11:30

      A 4: Pharmacological vasodilation and gas switching to carbon tetrafluoride during decompression to attenuate DCS
      Weis TW, Wilbur JC, Knaus DA, Buckley JC, Vann RD, Sevick JR, Stump DA, Deal DD, Ramsey M, Natoli MJ, Fellows A, Marshall C, Magari PJ, Cooter M, Moon RE
      Presenting Author: Trevor Weis

      11:30 AM

      12:00 PM

      Poster Session A

      Fiesta 7-10

       

      A 1: Heliox in-water decompression schedules for the interspiro is-mix mine clearance diving system
      Bouak F, van Ooij PJ, Nishi R, van Hulst RA
      Presenting Author: Pieter-Jan van Ooij, PHD


      A 2:
      Provocative decompression causes diffuse vascular injury mediated by interleukin (IL)-1β and inhibited by hyperbaric oxygen (HBO2).
      Thom SR, Bhopale VM, Yang M
      Presenting Author: Stephen R Thom, MD

      A 3:
      The effect of intermittent normobaric hyperoxia on stem cell mobilization and cytokine expression
      MacLaughlin KJ, Barton G, Braun R, Sobakin A, Eldridge M
      Presenting Author: Kent MacLaughlin 

      A 4: Pharmacological vasodilation and gas switching to carbon tetrafluoride during decompression to attenuate DCS
      Weis TW, Wilbur JC, Knaus DA, Buckley JC, Vann RD, Sevick JR, Stump DA, Deal DD, Ramsey M, Natoli MJ, Fellows A, Marshall C, Magari PJ, Cooter M, Moon RE
      Presenting Author: Trevor Weis

      A 5:
      Oxygen pre-breathe and decompression sickness outcomes in the uw sheep model
      Sobakin AS, Eldridge MW
      Presenting Author: Aleksey Sobakin, PHD

      A 6:
      Microparticle and interleukin (IL)-1β production associated with human high pressure exposures
      Brett KD, Nugent NZ, Fraser KN, Bhopale VM, Yang M, Thom SR
      Presenting Author: Kaighley Brett, MD

      A 7: Hyperbaric and high-oxygen environments accelerate muscle strength recovery in contused rat skeletal muscle
      Naoki Yamamoto
      Presenting Author: Naoki Yamamoto, MD

      A 8:
      Effects of a hyperbaric environment on antioxidative mechanisms in the mouse.
      Masaki H, Akira K, Naoki Y, Toshihiro K, Kazuyoshi Y
      Presenting Author: Masaki Horie, PHD

      A 9: Consistency of venous gas emboli status after three controlled pool diving exposures: a pilot study
      Denoble PJ, Papadopoulou V, Buzzacott P, Edelson CJ, Pieri M, Cialoni D, Lambrechts K, Balestra C, Marroni A
      Presenting Author: Petar Denoble, MD

      A 10: Augmentation of event related brain activity on cognitive control under hyperbaric environment
      Fujii T
      Presenting Author: Tatsufumi Fujii

      A 11: Effect of rehydration schedule after four-hour head out water immersion on running performance and recovery
      Stansbery RL, Hess HW, Schlader ZJ, Pendergast DR, Russo LN, Hostler D
      Presenting Author: Rebeccah Stansbery

      A 12: Cold water submersion attenuates post-submersion aerobic performance irrespective of rehydration strategy
      Hess HH, Schlader ZJ, Russo LN, Clemency BM, Stooks JJ, Carden CR, Hostler D
      Presenting Author: Hayden W Hess 

      A 13: Adapting contrast-enhanced imaging techniques to improve quantification of decompression bubbles in humans
      Hensel JSE, Le DQ, Balestra C, Tang M-X, Dayton PA, Papadopoulou V
      Presenting Author: James S. E. Hensel 

      A 14: Orthostatic intolerance following cold seawater submersion is likely independent of changes in body fluid status
      Hess H, Russo LN, Clemency BM, Stooks J, Carden C, Hostler D
      Presenting Author: Zachary J. Schlader, PHD

      A 15: Quantifying pathologic changes in the heart and lung of swine due to “yo-yo” and square dive protocols
      Ofir D, Arieli Y, Mullokandov M, Liboff A, Yanir Y
      Presenting Author: Dror Ofir, PHD

      2:00 PM

      3:00 PM

      Session B: HBO2 Therapy Mechanisms: Oral Presentations

      Fiesta 5

      2:00 - 2:15

      B 1: Oxygen microbubbles relieve tumor hypoxia and improve radiotherapy tumor control in a rat fibrosarcoma model
      Fix SM, Papadopoulou V, Velds H, Slagle C, Kasoji SK, Rivera JN, Borden MA, Chang S, Dayton PA
      Presenting Author: Samantha M. Fix

      2:15 - 2:30

      B 2: A hyperbaric and high-oxygen environment accelerates IL-6 synthesis, activates the IL-6/STAT3 pathway and suppress NFκB in rat contused skeletal muscle
      Oyaizu T, Enomoto M, Horie M, Yamamoto N, Yagishita K
      Presenting Author: Takuya Oyaizu, MD

      2:30 - 2:45

      B 9: Ketosis as a neuroprotective mechanism to CNS Oxygen Toxicity (CNSOT) in divers exposed to high partial pressures of oxygen (PO2)
      Dituri J, Renaldo C, Quirk B, D’Agostino D, Ari C, Annis H, Whelan HT
      Presenting Author: Harry T. Whelan, MD

      2:45 - 3:00

      B 8: Hyperbaric oxygen therapy for compromised flaps: Is there a role for delayed treatment?
      Francis A, Goldman JJ, Kleban SR, McNicoll CF, Mehta A, Phalke N, Doyle G, Nakhaima S, Rovig J, Williams SJ, Cross CL, Fang XH, Wang WZ, Baynosa RC
      Presenting Author: Aradhana Mehta, MD

      3:30 PM

      4:00 PM

      Poster Session B

      Fiesta 7-10

       

      B 1: Oxygen microbubbles relieve tumor hypoxia and improve radiotherapy tumor control in a rat fibrosarcoma model
      Fix SM, Papadopoulou V, Velds H, Slagle C, Kasoji SK, Rivera JN, Borden MA, Chang S, Dayton PA
      Presenting Author: Samantha M. Fix

      B 2: A hyperbaric and high-oxygen environment accelerates IL-6 synthesis, activates the IL-6/STAT3 pathway and suppress NFκB in rat contused skeletal muscle.
      Oyaizu T, Enomoto M, Horie M, Yamamoto N, Yagishita K
      Presenting Author: Takuya Oyaizu, MD

      B 3:
      Anti-inflammatory ability of Hyperbaric Oxygen Therapy (HBO-T) in patients with osteonecrosis
      Bosco G, Vezzani G, Rizzato A, Malacrida S, Abou-samra A, Mrakic-Sposta S, Enten G, Camporesi E
      Presenting Author: Gerardo Bosco, MD

      B 4: Effects of high-intensity interval training while in a hyperbaric oxygen environment on exercise performance
      DeCato TW, Wilson EL, Weaver LK, Hegewald MJ
      Presenting Author: Matthew Hegewald, MD

      B 5: Aseptic Condylar Necrosis and hyperbaric oxygen therapy
      Enten G, Bosco G, Vezzani G, Manelli D, Rao N, Mangar D, Bernasek T, Camporesi E
      Presenting Author: Enrico M. Camporesi, MD

      B 6: Hyperbaric oxygen therapy ameliorates osteonecrosis in patients by modulating inflammation and oxidative stress
      Camporesi E, Enten G, Vezzani G, Rizzato A,  Bosco G
      Presenting Author: Enrico M. Camporesi, MD

      B 7: WITHDREW

      B 8: Hyperbaric oxygen therapy for compromised flaps: Is there a role for delayed treatment?
      Francis A, Goldman JJ, Kleban SR, McNicoll CF, Mehta A, Phalke N, Doyle G, Nakhaima S, Rovig J, Williams SJ, Cross CL, Fang XH, Wang WZ, Baynosa RC
      Presenting Author: Aradhana Mehta, MD

      B 9: Ketosis as a neuroprotective mechanism to CNS Oxygen Toxicity (CNSOT) in divers exposed to high partial pressures of oxygen (PO2)
      Dituri J, Renaldo C, Quirk B, D’Agostino D, Ari C, Annis H, Whelan HT
      Presenting Author: Harry T. Whelan, MD

      B 10: Investigation of a cell-permeable mitochondrial prodrug on mitochondrial function in human blood cells from patients with CO poisoning
      Jang DH, Khatri UG, Kelly MP, Lambert DK, Hardy K
      Presenting Author: Matthew Kelly, MD

      B 11: Physiologic and cognitive effects of nutritional ketosis, elevated PO2 and exercise (KetOX Study)
      Keuski BM, Freiberger JJ, Moon RE, Richardson C, Natoli MJ, Schinazi EA, D’Agostino DP, Kuchibhatla M, Tomoye EO, Derrick BJ
      Presenting Author: Brian M. Keuski, MD

      B 12: Supraventricular Tachycardia during hyperbaric oxygen treatment
      Mihai A, Morgan M, Heyboer M
      Presenting Author: Aurel Mihai, MD

      B 13: Ketogenic diet for reduction of CNS oxygen toxicity in working divers (KetOX Study)
      Keuski BM, Freiberger JJ, Moon RE, Richardson C, Natoli MJ, Schinazi EA, D’Agostino DP, Kuchibhatla M, Tomoye EO, Derrick BJ
      Presenting Author: Brian Keuski, MD

      B 14: Last resort salvage of failed below knee amputations
      Strauss MB, Lu LQ
      Presenting Author: Michael Strauss, MD

      B 15:
      Decompression sickness in the multiplace hyperbaric chamber attendant
      Koca E, Mirasoglu B
      Presenting Author: Eylem Koca, MD

      FRIDAY, June 29

      10:30 AM

      11:30 AM

      Session C: Diving and Decompression Illness: Oral Presentations

      Fiesta 5

      10:30 - 10:45

      C 1: CNS oxygen toxicity – models vs practice
      Garbino A, Walker S, Sanders R
      Presenting Author: Alejandro Garbino, MD

      10:45 - 11:00

      C 3: Recreational diving related injuries among insured Divers Alert Network Japan members: Retrospective analysis of 321 cases from 2010 to 2014
      Kojima Y, Suzuki S, Niizeki Y, Kojima A, Kawaguchi H, Yagishita K
      Presenting Author: Yasushi Kojima, MD

      11:00 - 11:15

      C 4: Pulmonary fluid shifts are a common result of SCUBA diving exposures
      Sanders RW, Williams S, Ray K
      Presenting Author: Robert Sanders, MD

      11:15 - 11:30

      C 5: Analysis of 500 self-reported recreational scuba diving incidents
      Buzzacott P, Bennett CM, Denoble PJ
      Presenting Author: Peter Buzzacott, PHD

      11:30 AM

      12:00 PM

      Poster Session C

      Fiesta 7-10

       

      C 1: CNS oxygen toxicity – models vs practice
      Garbino A, Walker S, Sanders R
      Presenting Author: Alejandro Garbino, MD

      C 2: Withdrawn

      C 3: Recreational diving related injuries among insured Divers Alert Network Japan members: Retrospective analysis of 321 cases from 2010 to 2014
      Kojima Y, Suzuki S, Niizeki Y, Kojima A, Kawaguchi H, Yagishita K
      Presenting Author: Yasushi Kojima, MD

      C 4: Pulmonary fluid shifts are a common result of scuba diving exposures
      Sanders RW, Williams S, Ray K
      Presenting Author: Robert Sanders, MD

      C 5: Analysis of 500 self-reported recreational scuba diving incidents
      Buzzacott P, Bennett CM, Denoble PJ.
      Presenting Author: Peter Buzzacott, PHD

      C 6: Risk factors for middle ear barotrauma in subjects undergoing hyperbaric oxygen therapy
      Hatch JL, Wieland AM, High R, Cooper JS
      Presenting Author: Jeffrey Cooper, MD

      C 7: A Decompression stop for fishermen divers of the Yucatán Peninsula
      Chin W, Lik U, Huchim O, Markovitz G, Galovich J
      Presenting Author: Walter Chin, RN/CHRN

      C 8: Upper and lower extremity altitude chamber DCS
      Hayes, WA
      Presenting Author: William A Hayes II, DO

      C 9: Who’s listening? Ear health and diving: data from 790 divers
      St Leger Dowse M, Waterman M. Jones R, Smerdon GR.
      Presenting Author: Marguerite St Leger Dowse

      C 10: Ten year period prevalence of decompression illness among small-scale fishermen divers
      Chin W, Ramachandran M, Huchim-Lara O
      Presenting Author: Walter Chin, RN/CHRN

      C 11: Cerebrovascular Responses to Thermoneutral Head Out Water Immersion
      Schlader ZJ, Sackett JR
      Presenting Author: Blair D. Johnson, PHD

      C 12: Rater reliability of a transthoracic bubble study among fishermen divers of the Yucatán Peninsula
      Chin W, Huchim O, Endo B, Medak A, Ramachandran M, Popa D
      Presenting Author: Walter Chin, RN/CHRN

      C 13: Prevalence of Right-to-Left Shunt among Fishermen Divers of the Yucatán Peninsula
      Chin W, Huchim O, Endo B, Medak A, Ramachandran M, Popa D
      Presenting Author: Brandon Endo, MD

      C 14: Bubbles in vascular plexuses of the skin in the cutaneous decompression sickness. Report of cases
      Garcia E, Galicia P, Villanueva V.
      Presenting Author: Eduardo Garcia, MD

      C 15: Treatments of Dysbaric Osteonecrosis
      Kawashima M, Kawashima M, Tamura H, Nagayoshi I, Furue Y, Motoyama T, Sasaki T, Watanabe Y, Goto T, Takao K, Yamaguchi T, Miyata K.
      Presenting Author: Mahito Kawashima, MD

      12:00 PM

      12:30 PM

      Poster Session C

      Fiesta 7-10

       

      C 16: Perilymphatic fistula after diving: a case series
      Johnson-Arbor K
      Presenting Author: Kelly Johnson-Arbor, MD

      C 17:  Effect of single breath oxygen on breath-hold time
      Weaver AL, Weaver LK, Deru K
      Presenting Author: Anika Weaver 

      C 18: Physical disabilities after decompression illness among small-scale fishermen divers of the Yucatán Peninsula
      Aguiñaga S., Huchim-Lara O., Chin W.
      Presenting Author: Sofia Aguinaga 

      C 19: Oxygen exposures at NASA’s neutral buoyancy lab: a 20-year experience
      Walker SC, Garbino A, Ray K, Hardwick R, Fitzpatrick DT, Sanders RW
      Presenting Author: Robert Sanders, MD

      C 20: Estimated workload intensity during volunteer aquarium dives
      Buzzacott P, Grier JW, Walker J, Bennett CM, Denoble PJ
      Presenting Author: Peter Buzzacott, PHD

      C 21: Successful treatment of decompression illness complicated with acute hepatic infarction and acute kidney injury: A case report
      Oh SH, Choi SC, Cha YS, Lee YH, Kim GW, Kim H
      Presenting Author: Se Hyun Oh, MD

      C 22: Recurrent facial baroparesia: A case report
      Gomez-Castillo JD, Esquivel-Garcia B
      Presenting Author: Dario Gomez, MD

      C 23: Hyperbaric oxygen therapy for Type-II DCS in an experienced dive master – A case study
      Boes T, Morgan M, Sharma D, Santiago W, Mariani P, Heyboer M
      Presenting Author: Tanner Boes, MD

      C 24: hyperbaric oxygen therapy for type-i dcs secondary to Hypobaric Challenge – A case study
      Boes T, Morgan M, Sharma D, Santiago W, Mariani P, Heyboer M
      Presenting Author: Tanner Boes, MD

      C 25: Urinary obstruction following octopus bite
      Weaver, LK
      Presenting Author: Lindell K. Weaver, MD

      C 26: DCS with incidental pulmonary cyst
      Norton M, Weaver L, Uchida D
      Presenting Author: Mariesa N. Norton, ACNP/PA

      C 27: Unusual response to a presumptive stingray spine injury
      Do R, Lu LQ, Strauss MB
      Presenting Author: Michael B. Strauss, MD

      C 28: The impact of hyperbaric oxygen therapy on chronic Lyme disease:  A case study
      Linden RO, Zacher JE, LeDez KM, Cook T
      Presenting Author: Ron Linden, MD

      C 29:
      A pilot study evaluating knowledge of indications for hyperbaric oxygen therapy among physicians in Mid-Michigan
      Jones MW, Henning WH
      Presenting Author: Werner Henning, DO

      C 30:
      Underwater nasal decongestant use: A novel approach to middle ear equalization during a dive
      Covington DB, Pitkin AD
      Presenting Author: Derek Covington, MD

      2:00 PM

      3:00 PM

      Session D: Diving and Decompression Illness: Oral Presentations

      Fiesta 5

      2:00 - 2:15

      D 1: A randomized trial of one v. three hyperbaric oxygen sessions for acute carbon monoxide poisoning
      Weaver LK, Churchill S, Deru K, Handrahan D
      Presenting Author: Lindell K. Weaver, MD

      2:15 - 2:30

      D 2: A clinical practice guideline for the prevention and treatment of Mandibular Osteoradionecrosis (ORN) applying  GRADE methodology.
      UHMS CPG Authors: Feldmeier JJ,  DuBose KJ, Gesell LB,  Shah JB,  Huang ET, Mansouri J, Marx RE
      UHMS CPG Oversight Committee:  Feldmeier JJ, LeDez K, Le PNJ, Mansouri J, Moon R, Murad MH
      Presenting Author: John Feldmeier, DO

      2:30 - 2:45

      D 3: Sleep assessment in a randomized trial of hyperbaric oxygen in U.S. service members with post-concussive symptoms
      Walker JM, Mulatya C, Hebert D, Wilson SH, Lindblad AS, Weaver LK
      Presenting Author: Lindell K. Weaver, MD

      2:45 - 3:00

      D 4: A composite outcome for mild traumatic brain injury in trials of hyperbaric oxygen
      Weaver LK, Churchill S, Wilson SH, Hebert D, Deru K, Lindblad AS
      Presenting Author: Steffanie Wilson, PHD

      3:30 PM

      4:00 PM

      Poster Session D

      Fiesta 7-10

       

      D 1: A randomized trial of one v. three hyperbaric oxygen sessions for acute carbon monoxide poisoning
      Weaver LK, Churchill S, Deru K, Handrahan D
      Presenting Author: Lindell K. Weaver, MD

      D 2: A clinical practice guideline for the prevention and treatment of Mandibular Osteoradionecrosis (ORN) applying  GRADE methodology
      UHMS CPG Authors: Feldmeier JJ,  DuBose KJ, Gesell LB,  Shah JB,  Huang ET, Mansouri J, Marx RE
      UHMS CPG Oversight Committee:  Feldmeier JJ, LeDez K, Le PNJ, Mansouri J, Moon R, Murad MH
      Presenting Author: John Feldmeier, DO

      D 3: Sleep assessment in a randomized trial of hyperbaric oxygen in U.S. service members with post-concussive symptoms
      Walker JM, Mulatya C, Hebert D, Wilson SH, Lindblad AS, Weaver LK
      Presenting Author: Lindell K. Weaver, MD

      D 4: A composite outcome for mild traumatic brain injury in trials of hyperbaric oxygen
      Weaver LK, Churchill S, Wilson SH, Hebert D, Deru K, Lindblad AS
      Presenting Author: Steffanie Wilson, PHD

      D 5: Hyperbaric oxygen therapy effect on patients suffering from fibromyalgia due to childhood sexual abuse – randomized controlled trial
      Hadanny A, Bechor Y, Catalogna M, Daphna S, Lev R, Efrati S
      Presenting Author: Amir Hadanny, MD

      D 6: Hyperbaric oxygen for TBI and PTSD: A meta-analysis of Department of Defense and other published study results
      Hart BB, Weaver LK, Gupta A, Wilson SH, Vifayarangan A, Deru K, Hebert D
      Presenting Author: Brett Hart, MD

      D 7: Hyperbaric oxygen therapy can rescue ischemic breast flaps following skin-sparing mastectomy
      Rajpal N, Walters E, Elmarsafi T, Johnson-Arbor K, Pittman T
      Presenting Author: Kelly Johnson-Arbor, MD

      D 8: A retrospective analysis of treatment of wounds caused by Calciphylaxis: Hyperbaric oxygen therapy with and without Sodium Thiosulfate
      Armour D, Tailor Y, Preston-Hsu E
      Presenting Author: Doris Armour, MD

      D 9: The effect hyperbaric oxygen on erectile dysfunction – Pilot study
      Hadanny A, Lang E, Copel L, Meir O, Bechor Y, Fishlev G, Bergan J, Zisman A, Efrati S
      Presenting Author: Amir Hadanny, MD

      D 10: Effects of hyperbaric oxygen therapy on non-diabetic serum glucose levels
      Boes T, Wojcik S, Heyboer M, Seargent S
      Presenting Author: Tanner Boes, MD

      D 11: Case series review: Multicenter experience treating Idiopathic Sudden Sensorineural Hearing Loss (ISSHL) with adjunctive hyperbaric oxygen therapy
      Robins MS, Gwilliam A, Weaver LK, Churchill S, Deru K, Cascio M, Pollack R, Nail S
      Presenting Author: Marc Robins, DO

      D 12:
      Hyperbaric oxygen treatment course completion and time to drop-out in a large outpatient sample
      Brailsford JB, Gordon HM, Ennis, WJ
      Presenting Author: Jennifer Brailsford, PHD

      D 13: Advanced wound care assessment as a pre-cursor to HBO2: Improving diabetic foot ulcer outcomes
      Tremblay R, Michael M
      Presenting Author: Roma Tremblay, PHD

      D 14: Hyperbaric oxygen therapy: A review of adverse event rates during treatment for Radiation Cystitis
      Owen E, Perdrizet G
      Presenting Author: Elizabeth Owen, MD

      D 15: Appraisal of six wound scoring systems and the Long Beach Wound Score
      Strauss MB, Moon H, Botros M, Lu LQ
      Presenting Author: Michael B. Strauss, MD

      4:00 PM

      4:30 PM

      Poster Session D

      Fiesta 7-10

       

      D 16: Spinal cord radiation injury reversed by hyperbaric oxygen therapy
      Cianci PE, Costello PJ
      Presenting Author: Paul Cianci, MD

      D 17: Adjunctive hyperbaric oxygen therapy with isavuconizonium in the treatment of Mucor
      Evangelista J
      Presenting Author: Jose Evangelista, MD

      D 18: Impact of hyperbaric oxygen therapy in a child with delayed soft tissue radiation necrosis of the brain.
      Dapena JC, Siegel M
      Presenting Author: Juan C. Dapena, MD

      D 19:
      Hyperbaric oxygen therapy for the treatment of delayed frostbite injury
      Johnson-Arbor K
      Presenting Author: Kelly Johnson-Arbor, MD

      D 20: Use of hyperbaric oxygen therapy for lower extremity sickle cell ulcerations
      Johnson-Arbor K
      Presenting Author: Kelly Johnson-Arbor, MD

      D 21: Use of hyperbaric oxygen therapy for treatment of acute skin necrosis after a “Brazilian Butt Lift”
      Johnson-Arbor K
      Presenting Author: Kelly Johnson-Arbor, MD

      D 22: Decision making for limb threatening wounds
      Strauss MB, Moon H, Miller SS, Lu LQ
      Presenting Author: Michael B. Strauss, MD

      D 23: Case report: High-throughput enterocutaneous fistula and the role of HBO2
      Borges HL, Oliveira N, Paz MA, Santos PE, Toni JP
      Presenting Author: Hugo Borges, MD

      D 24:
      Case Report: HBO2 avoiding amputation in serious osteomyelitis of ankle
      Borges HL, Oliveira N, Paz MA, Santos PE, Toni JP
      Presenting Author: Hugo Borges, MD

      D 25: Femoropopliteal doppler velocities associated with hyperbaric oxygen treatment session of diabetic patients with leg ulcers
      Maran CA, Salles-Cunha SX, Millazo PAA, Farias PSR, Castro IJL, David JRN, David RAR
      Presenting Author: Maran Cristiane Antequeira, MD

      D 26: Smoking paradox in the development of delayed neuropsychiatric sequelae among acute carbon monoxide (CO) intoxication patients with hyperbaric oxygen therapy
      Lee Y
      Presenting Author: Younghwan Lee, MD

      D 27: The historical priority of South America in hyperbaric research and practice
      Brito T, Subbotina N
      Presenting Author: Tomaz Brito, MD and Nina Subbotina, MD

      D 28: Successful artificial sphincter placement for urinary incontinence in the setting of radiation cystitis with adjunctive hyperbaric oxygen therapy – A case study
      Boes T, Morgan M, Sharma D, Santiago W, Mariani P, Heyboer M
      Presenting Author: Tanner Boes, MD

      D 29: Hyperbaric Oxygen Treatments for vasculitis induced by levamisole containing cocaine
      Ptak J, Reetz S, Buckey J
      Presenting Author: Judy Ptak, RN/CHRN

      D 30: Closing RICH-ART study:  Radiation induced cystitis treated with hyperbaric oxygen – A randomized controlled trail
      Oscarsson N, Bueller B, Seeman-Lodding H
      Presenting Author: Nicklas Oscarsson, MD

      SATURDAY, June 30

      10:30 AM 11:30 AM Session E: HBO2 Therapy, Chambers, and Equipment: Oral Presentations Fiesta 5

      10:30-10:45

      E 5: Interim analysis of mucosal atomizer use to maintain myringotomy patency during elective hyperbaric treatments
      Walter J, Westgard B, Hendriksen S, Masters T, Logue C
      Presenting Author: Joe Walter, MD

      10:45-11:00

      E 2: Hyperbaric oxygen simulation education
      Arefieva CA, Duchnick J, Bermudez R, Witucki P, Shishlov K, Sadler C
      Presenting Author: Christa Arefieva

      11:00-11:15

      E 3: Performance characteristics of high frequency percussive ventilation (HFPV) under hyperbaric conditions
      Huang ET, Heltborg JL, Apsey RT, Ray K
      Presenting Author: Kristi Ray, MD

      11:15-11:30

      E 4: Observations on O2% during air breathing periods using a non-rebreather face mask in a monoplace chamber
      Bell J , Koumandakis G, Churchill S , Weaver LK
      Presenting Author: James Bell, CHT

      11:30 AM

      12:00 PM

      Poster Session E

      Fiesta 5

       

      E 1: Preprogramed bailout and surface decompression schedules for multiplace treament profiles
      Raleigh GW
      Presenting Author: Greg Raleigh, CHT

      E 2: Hyperbaric oxygen simulation education
      Arefieva CA, Duchnick J, Bermudez R, Witucki P, Shishlov K, Sadler C
      Presenting Author: Christa Arefieva, 

      E 3:
      Performance characteristics of high frequency percussive ventilation (HFPV) under hyperbaric conditions
      Huang ET, Heltborg JL, Apsey RT, Ray K
      Presenting Author: Kristi Ray, MD

      E 4: Observations on O2% during air breathing periods using a non-rebreather face mask in a monoplace chamber
      Bell J , Koumandakis G, Churchill S , Weaver LK
      Presenting Author: James Bell, CHT

      E 5: Interim analysis of mucosal atomizer use to maintain myringotomy patency during elective hyperbaric treatments
      Walter J, Westgard B, Hendriksen S, Masters T, Logue C
      Presenting Author: Joe Walter, MD

      E 6:
      Multiplace hyperbaric chamber modifications for safe utilization of a non-hyperbaric rated cardiac monitor
      Bliss C, Mosteller J
      Presenting Author: Chae Bliss, CHT

      E 7:
      Leg ulcer characterization by photographic imaging pre and post hyperbaric oxygen treatment: Lessons learned with first 10 cases
      Maran CA, Salles-Cunha SX, Millazo PAA, Farias PSR, Castro IJL, David JRN, David RAR
      Presenting Author: Maran Cristiane Antequeira, MD

      E 8: Responding to an active shooter – Learning from one facility’s experience
      Ptak J, Cormier J
      Presenting Author: Judy Ptak, RN/CHRN

      E 9: Use of High Frequency Percussive Ventilation (HFPV) in a patient with carbon monoxide poisoning
      Huang ET, Heltborg JL, Apsey RJ
      Presenting Author: Enoch Huang, MD

      E 10: continuous bladder irrigation in the monoplace hyperbaric chamber: A cautionary tale
      Cooper JS, Lagrange CA
      Presenting Author: Jeffrey Cooper, MD

      E 11: The use of indocyanine green fluorescence angiography to assess perfusion of chronic wounds undergoing hyperbaric oxygen therapy
      Kim DU, Rao A, Kaplan S, Baksh F, Caprioli R,  Haight J, Ferguson RG, Pliskin M, Oropallo A
      Presenting Author: Alisha Oropallo, MD

      E 12: Utilization of fluorescence microangiography (LUNA) in a pediatric patient with acute compartment syndrome
      Walter J, Settypalli S, Westgard B, Hendriksen S, Masters T, Logue C
      Presenting Author: Joe Walter, MD

      E 13: Public awareness of carbon monoxide poisoning
      Gwilliam AM, Williams B, Stewart JR, Robins MS
      Presenting Author: Annette Gwilliam, RN/CHRN

      E 14:
      Surviving an active shooter event
      Brown P
      Presenting Author: Paul Brown, CHT

      E 15:
      Compartment syndrome of the forearm related to carbon monoxide intoxication
      Kim GW
      Presenting Author: Gi Woon Kim, MD

      2:00 PM

      3:00 PM

      Session F: Top Case Reports: Oral Presentations

      Fiesta 5

      2:00-2:10

      F 1: Case series of central retinal artery occlusion followed with bedside ultrasound
      Hendriksen SM, Masters TC, Westgard BC, Walter JW, Logue CJ
      Presenting Author: Stephen Hendriksen, MD

      2:10-2:20

      F 2: AGE during controlled ascent training in a Navy Diver trainee: A case report with video registration of the accident
      Wingelaar TT, van Ooij PJ, Koch D
      Presenting Author: Thijs Wingelaar, MD

      2:20-2:30

      F 3: Reversal of central pontine myelinolysis symptoms with hyperbaric oxygen therapy
      Bensusan AB, Staab P, LeGros TL, Murphy-Lavoie H
      Presenting Author: Ariana P Bensusan, DO

      2:30-2:40

      F 4: Taravana: A syndrome revisited, A case report
      Derksen BD, Savaser DJ
      Presenting Author: Brenna Derksen, MD

      2:40-2:50

      F 5: Acute scalp necrosis successfully treated with hyperbaric oxygen therapy
      Johnson-Arbor K
      Presenting Author: Kelly Johnson-Arbor, MD

      2:50-3:00

      F 6: Delayed hyperbaric oxygen therapy for cerebral arterial gas embolism following scuba diving: A case report.
      Brett KD, Boni B, Latham E, Sadler C
      Presenting Author: Kaighley Brett, MD

      3:30 PM

      4:00 PM

      Poster Session F

      Fiesta 7-10

       

      F 1: Case series of central retinal artery occlusion followed with bedside ultrasound
      Hendriksen SM, Masters TC, Westgard BC, Walter JW, Logue CJ
      Presenting Author: Stephen Hendriksen, MD

      F 2: AGE during controlled ascent training in a Navy Diver trainee: A case report with video registration of the accident
      Wingelaar TT, van Ooij PJ, Koch D
      Presenting Author: Thijs Wingelaar, MD

      F 3: Reversal of central pontine myelinolysis symptoms with hyperbaric oxygen therapy
      Bensusan AB, Staab P, LeGros TL, Murphy-Lavoie H
      Presenting Author: Ariana P Bensusan, DO

      F 4: Taravana: A syndrome revisited, A case report
      Derksen BD, Savaser DJ
      Presenting Author: Davut Savaser, MD

      F 5: Acute scalp necrosis successfully treated with hyperbaric oxygen therapy
      Johnson-Arbor K
      Presenting Author: Kelly Johnson-Arbor, MD

      F 6: Delayed hyperbaric oxygen therapy for cerebral arterial gas embolism following scuba diving: A case report.
      Brett KD, Boni B, Latham E, Sadler C
      Presenting Author: Kaighley Brett, MD
       
      F 7: A case of trigeminal neuralgia treated with hyperbaric oxygen
      Huang ET
      Presenting Author: Enoch Huang, MD

      F 8: Cerebral AGE from upper endodoscopy
      Popa DA, Witucki P
      Presenting Author: Daniel Popa, MD

      F 9: Hyperbaric oxygen for late sequelae of carbon monoxide poisoning enhances neurological recovery
      Keim LW, Koneru S, Ramos V, Murr N, Hoffnung DS, Murman DL,  Cooper JS, Torres-Russotto D
      Presenting Author: Jeffrey Cooper, MD

      F 10: Facial baroparesis as a complication of HBO2: A previously unreported cause of a rare condition
      Sayers MP, Lopez E, Gutfreund Y
      Presenting Author: Martin P Sayers, MD

      F 11: Cerebral arterial gas embolism in a scuba instructor: An interesting cause
      Garcia E, Galicia P, Villanueva V
      Presenting Author: Eduardo Garcia, MD

      F 12: WITHDREW

      F 13: Hypoglycemia after scuba diving with insulin pump
      Gomez-Castillo JD, Contreras U, Reyes-Silva KN
      Presenting Author: Jorge Dario Gomez Castillo, MD

      F 14: Lyme disease developing during hyperbaric oxygen treatments
      Ptak J, Reetz S, Buckey J
      Presenting Author: Judy Ptak, RN/CHRN

      F 15: Case report: The role of HBO2 in a spider bite
      Borges HL, Oliveira N, Paz MA, Santos PE, Toni JP
      Presenting Author: Hugo Borges, MD

       


       

       

      Read more

    Read more

  • Keynote Lectures

    • CHRISTIAN J. LAMBERTSEN MEMORIAL LECTURE
      THURSDAY, JUNE 28: 1:00 pm - 2:00 pm

      vanmeter keithGUEST SPEAKER: Keith Van Meter, MD
      LECTURE TITLE: "A long shot to a short shot: Hyperbaric Oxygen augmented ACLS/ATLS spawned by commercial diving medicine experience"


      ABOUT THE LECTURE:
      The presentation will focus on observations gleaned from a forty-year history of responding to accidents on oil rigs and diving platforms in the Gulf of Mexico to care for seriously injured commercial divers. This experience afforded a look into the advantage of immediate use of high surface equivalent fraction of inhaled oxygen (SEFIO2) applied in short, intermittent breathing periods in the hyperbaric environment.  Divers suffering from exsanguination, cardiopulmonary arrest, crush injury and severe heat shock have been successfully treated coincidentally because of requisite hyperbaric oxygen administration during surface or saturation decompression.

      The favorable patient outcomes have been replicated in published animal experiments. In part, the physiological explanation might be better understood by looking into the role of mitochondria in shock. The hyperbaric chamber may be a virtual drawer of a code cart in future emergency medical systems and hospitals to improve outcomes from ACLS and ATLS.

      ABOUT  DR. VAN METER: 
      Dr. Van Meter attended George Washington School of Medicine in Washington, D.C. He trained at Tulane University / Charity Hospital in New Orleans, Louisiana. He is currently board certified in Emergency Medicine, Undersea and Hyperbaric Medicine, Pediatric Emergency Medicine, and Medical Toxicology. He has performed and published research in a number of topics. His current focus is on the use of hyperbaric medicine as an adjunct to ACLS and ATLS both in the clinical hospital setting and in the pre-hospital arenas.

                  Dr. Van Meter is the President and Medical Director of an emergency physician group which staffs a number of contracts in Louisiana and Mississippi. He is lead physician for a first response flight team that treats offshore, injured commercial divers on-site. He is the Medical Director for Baromedical Research Institute, a facility that specializes in research in the field of Hyperbaric Medicine. He is a Clinical Professor both at LSU Health Sciences Center and Tulane University School of Medicine.

                  Since 1989, Dr. Van Meter has served as the Chief of the Section of Emergency Medicine at LSU Health Sciences Center in New Orleans. He has provided steadfast leadership at Charity Hospital’s Level I Trauma Center before and during Hurricane Katrina and afterward at the Interim LSU Hospital. At University Medical Center in New Orleans, he participates in the training and education of physicians on the front lines of emergency and hyperbaric medicine.


      CHRISTIAN J. LAMBERTSEN, MD, DSc (Hon) MEMORIAL LECTURE
      About Dr. Lambertsen:

      LAMBERTSEN PIC

      Dr. Christian J. Lambertsen received a B.S. Degree from Rutgers University in 1938 and a M.D. Degree from the University of Pennsylvania in 1943. During his medical school period, he invented and first used forms of the initial U.S. self-contained closed-circuit oxygen rebreathing apparatus, for neutral buoyancy underwater swimming and diving. As a student, he aided the early Office of Strategic Services (O.S.S.) in establishing the first cadres of U.S. military operational combat swimmers. Dr. Lambertsen became a U.S. Army medical officer on graduation from medical school in early 1943, and immediately joined the O.S.S. Maritime Unit on active duty through its period of function in World War II. He joined the University of Pennsylvania Medical Faculty in 1946, and became Professor of Pharmacology in 1952. While a faculty member he combined diving research and further underwater rebreathing equipment developments for the Army and Navy. In 1967 he served as Founding President of the Undersea Medical Society (now Undersea and Hyperbaric Medical Society.) Dr. Lambertsen is recognized by the Naval Special Warfare community as "The Father of U.S. Combat Swimming.” His hand has touched every aspect of military and commercial diving. Dr. Lambertsen’s active contributions to diving began during WWII and became even more progressive in the post-war period through the evolutions of the U.S. Navy Deep Submergence and Naval Special Warfare developmental programs. 

    • ERIC P. KINDWALL, MD MEMORIAL LECTURE
      FRIDAY, JUNE 29: 1:00 pm - 2:00 pm

      Eworth pic3GUEST SPEAKER: Eugene Worth, MD
      LECTURE TITLE: "HBOT and Diabetic Foot Ulcers: Do We Have a Leg to Stand On?"

      ABOUT THE LECTURE: 
      Use of hyperbaric oxygen as a means of therapy for the terrible complications of diabetes began in 1979 (Hart and Strauss). There have been at least 9 randomized controlled trials, of which 7 showed beneficial effects of hyperbaric oxygen as an adjunctive therapy combined with advanced wound care. Recently, there have been 3 negative studies (Margolis, et al; Fedorko, et al; and Santema, et al.) All three of these studies have been published in the same journal, Diabetes Care. (I wonder if that is by coincidence.)
           In this presentation, I will trace the history of HBOT and DFU. One of the overarching weaknesses in all of the trials is a simple fact: None of us practice ‘standard wound care’ or ‘advanced wound care’ in the same way. We can do a better job, and in today’s regulatory environment, we must improve.
           Finally, I will review papers disproving some regulatory fallacies. HBOT and DFU is cost-effective in a community limb salvage protocol. Hemoglobin A1c (HbA1c) has little or no bearing on whether a DFU will heal. Tight HbA1c control may lead to premature death from hypoglycemic episodes.
           My goal for each DFU is to leave the patient with an ambulatory extremity. Failure to do that hastens morbidity and mortality.  In summary, fasten your seatbelt. I will challenge current paradigms and lay out a pathway to improve patient care. Yes, we have a leg to stand on!

      ABOUT DR. WORTH: 
      Eugene R. Worth, MD, M.Ed., FABA, ABPM/UHM
      Dr. Eugene Worth is a retired Medical Director for Hyperbaric Medicine. He was most recently at Dixie Regional Medical Center in St. George, Utah. Dr. Worth received his A.B. and MD degrees from the University of Missouri-Columbia, in Columbia Missouri. He then completed an internship and residency in Anesthesiology at the University of Missouri-Columbia Hospital and Clinics.  He is a board-certified Anesthesiologist and has served in private and academic practices. His subspecialty area was cardiac and major vascular anesthesia including heart transplantation. He has practiced wound care and hyperbaric medicine since 2002 and is subspecialty board-certified in Undersea and Hyperbaric Medicine. He retired from daily practice on July 3, 2017 after 38 years as a physician. He is currently a private consultant and owner of Worth Hyperbaric Consulting, LLC. He and his lovely wife live in Kearney, Missouri.
           Dr. Worth completed a 3-year NIH-sponsored medical informatics fellowship (1994 – 1997) at the University of Missouri-Columbia. His Masters Degree is in Education, with an emphasis in curriculum and instruction and educational technology. His research involved using electronic mail discussion groups as “virtual colleagues,” enhancing information transfer to clinical practice by asymmetric communication.
           Dr. Worth has practiced undersea and hyperbaric medicine since 2002. In April, 2006, he became the medical director of Hyperbaric Medicine at the Utah Valley Regional Medical Center, Provo, Utah. In 2013, he was named the medical director at Dixie Regional Medical Center in St. George, Utah. He was an adjunct assistant professor for the Duke University Undersea and Hyperbaric Medicine program since 2013.
           Dr. Worth is a long-time member of the Undersea and Hyperbaric Medical Society. He has served on the Education and Safety Committees. He is a physician surveyor for the UHMS Accreditation Team.
           He is a recreational diver (PADI Advanced Open Water and Enriched Air) and a NOAA Diving Medical Officer. He has 30+ scientific publications, including two book chapters. He has given numerous presentations in anesthesiology, medical informatics, hyperbaric medicine and diving medicine.
           Dr. Worth is the recipient of a number of awards and distinctions in undersea and hyperbaric medicine. In 2017, he received the founding “Circle of Excellence Award” from the Baromedical Nurses Association. This award recognizes mentoring and support of hyperbaric nurses worldwide. He is a reviewer for the journal, Undersea and Hyperbaric Medicine.

      FABA = Fellow of the American Board of Anesthesiology
      ABPM/UHM = Sub-specialty certified in Undersea and Hyperbaric Medicine by the American Board of Preventive Medicine.
      NOAA = National Oceanic and Atmospheric Association


      ERIC P. KINDWALL, MD MEMORIAL LECTURE
      About Dr. Kindwall:

      KINDWALL PICDr. Kindwall is known by so many as the "Father of Hyperbaric Medicine.” Whether you knew him personally or simply by reputation, we have all benefited from his efforts, passion, wisdom, knowledge, energy and vision. Dr. Kindwall has played a great role in growing and shaping the specialty of Undersea and Hyperbaric Medicine. He was likewise instrumental in molding the UHMS into what it is today.  Dr. Kindwall began diving in 1950. He cultivated his interest in the field and during the Vietnam War served as the Assistant Director of the U.S. Navy School of Submarine Medicine. He also was the Senior Officer responsible for the Diving Medicine Program. In 1969, after leaving the Navy, Dr. Kindwall became Chief of the Department of Hyperbaric Medicine at St. Luke’s Medical Center, Milwaukee, Wis.  Shortly after the Undersea Medical Society was created in the mid-1960s, Dr. Kindwall identified the need for standardized education in the field. He created the UMS Education and Standards Committee to help elevate course content and ensure instructor competence. This committee later became our Education Committee. When the AMA initiated its Continuing Medical Education program, Dr. Kindwall persuaded the organization to recognize the UMS as a grantor of CME credits.  In 1972, Dr. Kindwall felt that the Society’s members would benefit from improved communication. He created our first newsletter and was named editor. Dr. Kindwall chose the name Pressure because clinical hyperbaric medicine was rapidly developing. Even though the UHMS had not yet incorporated "Hyperbaric” into the Society’s name, he wanted a title for the newsletter that would encompass all who worked with increased atmospheric pressure. He stated: "The Society’s goal then, as it is now, is to serve all who deal with the effects of increased barometric pressure.”  That same year, Dr. Kindwall recognized the need to have a relationship with Medicare to help provide insight on reputable clinical management. The UMS followed this lead, and a Medicare Panel was created. The recommendations were presented to the U.S. Public Health Service. The challenge was that no reliable hyperbaric medicine clinical guidelines were available that addressed appropriate applications of Hyperbaric Medicine. To remedy this deficit, the UMS Executive Committee created an Ad Hoc Committee on hyperbaric oxygen therapy. Dr. Kindwall was named Chair. The committee created the first Hyperbaric Oxygen Therapy Committee Report. Again, this text was published 10 years before the UHMS incorporated "Hyperbaric” into its name. The report was sent to HCFA and the Blues and became their source document for reimbursement. Dr. Kindwall updated the text two more times and thus was the Editor and Chair of the Committee and text for three of its 12 editions.  Dr. Kindwall later worked to expand the available information on the specialty by creating one of the first complete texts on the field. He created Hyperbaric Medicine Practice in 1994 and later updated and revised his text two more times.  The Society’s first journal, Hyperbaric Oxygen Review, has also has been influenced by Dr. Kindwall. His love for research and education was clear: He became the initial editor, creating a journal that at first consisted of review articles and one original contribution. Over the years,it has grown to one full of original research.  Dr. Kindwall’s presence is felt in so many of the UHMS’ activities and initiatives. Much of what we all take for granted – what is just "there” and "available” – has his touch and influence. Some of us have been blessed to have had a closer impact by Dr. Kindwall’s life, but I think that I can easily say that each of us has been influenced in some way.

       



    Read more

  • Plenary Sessions

    • Thursday, June 28

      HYPERBARIC MEDICINE AND CANCER PLENARY             MECHANISMS OF HBO PLENARY



      HYPERBARIC MEDICINE AND CANCER PLENARY
      8:30 AM - 10:00 AM

      0830-0915
      John Feldmeier, DO
      "Hyperbaric oxygen and cancer treatment with emphasis on its potential role combined with ketogenic diet and chemotherapy.

      Feldmeier Pic OfficialAt the same time, other researchers have advocated hyperbaric oxygen as a primary treatment for malignant conditions, though the support is limited here. A number of studies done in the late 1950s through the 1970s even on review many years later firmly establish simultaneous hyperbaric oxygen as a radiosensitizer. There are reasons to believe that sequential hyperbaric oxygen followed immediately by can enhance cancer cell kill. The pioneering work by several Japanese authors have reported encouraging results in applying this combined treatment in high-grade brain tumors. More recently, a similar study supported in part by the Baromedical Research Foundation has shown the feasibility of applying these principles to head and neck cancers receiving both chemotherapy and radiation therapy with impressive results and no unexpected toxicities.
           There is a strong rationale and a bit of research that also suggest that chemotherapy’s antitumor effects can be enhanced by hyperbaric oxygen as well. Certainly, the logistics of delivering chemotherapy in the hyperbaric chamber are much easier than delivering radiation with HBO2.

           In this session, Dr. John Feldmeier will introduce an overview of the above issues. These will include a discussion of the Warburg effect and its implications for combined HBO2 and chemotherapy and HBO2 combined with the ketogenic diet.  A brief update will be presented on the status of HBO2 alone and how it effects malignant growth. Other mechanisms by which chemotherapy delivery and tumoricidal effects can likely be enhanced will be considered. 
           Mr. Richard Clarke will follow with a lecture updating the experience in a multi-center trial using sequential HBO2 and radiation with chemotherapy in advanced head and neck cancer patients.

      0915-1000
      Dick Clarke, CHT
      "Hyperbaric Oxygen Radiation Sensitization of Squamous Cell Carcinomas of the Oropharynx"

      Clarke IMG 1761 2This presentation summarizes the first study of hyperbaric oxygen chemo-radiation sensitization for locally advanced squamous cell carcinomas of the oropharynx. It took the form of a Stage I dose escalation trial, designed to determine safety, feasibility and tolerability when hyperbaric oxygen was added to standard care: namely intensity modulated radiation therapy and cisplatinum chemotherapy. The presentation will describe the biological plausibility and physiologic basis for pre-radiation hyperbaric hyperoxia, and the rationale for selection of this tumor type and tumor grade. The hyperbaric dosing regimen, one based upon previous human tumor oxygen response curves, is discussed, and the critical time window for radiation therapy “beam on” from exiting the chamber discussed. Evolution from earlier sensitization studies that employed concurrent hyperbaric oxygen-radiation therapy to the modern sequential approach are described, as well as its inherent advantages. A staging protocol employed to titrate hyperbaric dose against possible acute toxicities is described. Acute toxicities and five-year follow-up results are presented, as is a Stage III study design, in the form of a randomized, sham controlled clinical double-blind trial.

       


      MECHANISMS OF HBO PLENARY
      4:00 PM - 5:00 PM
       

      1600-1700
      Stephen Thom, MD
      "Hyperbaric Oxygen Therapy Cell Signaling & Mechanisms of Action"

      thom


      This lecture will summarize current knowledge on mechanisms of action for hyperbaric oxygen (HBO2) therapy. Information will include findings from peer-reviewed publications involving both animal and human studies. It will emphasize data from human investigations, with a focus on those actions most relevant to clinical HBO2 indications.

      Read more

    • Friday, June 29

      RESEARCH AND REGISTRIES FOR HBOT PLENARY               HBO AND DFU PLENARY


       

      RESEARCH AND REGISTRIES FOR HYPERBARIC OXYGEN THERAPY PLENARY
      8:00 AM - 10:00 AM

      0800-0830
      Caroline Fife, MD
      "The Hyperbaric Oxygen Therapy Registry and the role of a Qualified Clinical Data Registry in protecting reimbursement"
      Caroline Fife1716
      The field of hyperbaric oxygen therapy and hyperbaric practitioners are under unprecedented scrutiny, with a resulting 50% decrease in HBO2 utilization nationally. Most practitioners are now subject to The Merit Based Incentive Payment System (MIPS), which requires the submission of quality measures. Qualified Clinical Data Registries (QCDRs) can develop specialty-specific quality measures and transmit data to CMS on behalf of clinicians, increasing the opportunity for bonus payments.
           The HBOTR, through the USWR, offers specialty registry participation as part of MIPS. Registry participation is possible via automated transmission of Continuity of Care Documents (CCDs) which can enable national benchmarking of many key parameters and can address patient selection bias for other types of registry participation by providing a “denominator” for patients/conditions treated. QCDRs manage identified data and can link to the Medicare data warehouse, facilitating HBO2 cost effectiveness research. Patient-reported questionnaires can be enshrined as quality measures, enabling practitioners to realize a small reimbursement benefit for performing them. Provider scores on specialty-specific quality measures are publicly available via the USWR website linked to “Physician Compare,” a welcome alternative to star ratings derived only from standard (and irrelevant) MIPS measures. Hyperbaric Centers may also benefit from quality measure reporting. The HBOTR leverages current mandatory reporting quality requirements and available electronic health record technology to automate registry participation, an important consideration given the lack of funding for HBO2 research.
           The HBOTR has already saved physician payment from a substantial reduction and can be harnessed for clinical research. Since January 2012, data on 27,404 patients has been captured. Among the 62,843 DFUs with data, 9,908 DFUs (15.7%) were treated with HBO2 therapy, although in 2017, the benchmark rate for HBOT was 7.3%, with an average of 28 treatments per patient. There are 2,100 providers who report data to the USWR by transmitting CCDs from their EHR and 688 who submit quality measure data, 300 (43.6%) of whom transmit HBO2 quality measure data.


      0830-0900
      Jay Buckey, MD

      "The hyperbaric medicine registry at Dartmouth"

      Buckey imageThe value of hyperbaric oxygen is being questioned even for well-established UHMS-approved indications. Although every hyperbaric center treats cases for established indications, the outcomes are not gathered together at a central site, analyzed, and published. As a result, outcome data for hyperbaric oxygen are limited and hard to find. An outcomes registry collects outcomes data from multiple sites consistently, which could allow for more powerful analyses, and more widely accessible results. This talk will describe the outcomes-focused hyperbaric registry currently in use at Dartmouth, and how it could be used to advance the field of hyperbaric medicine.



       0900-0930
      Judy Rees, MD, PhD
      "The role of registries in medicine"
      Rees imageThe goal of a disease or treatment registry is to document important data systematically from a sample of patients and use it to make inferences to a larger population. This presentation will consider how registries can be used, some of the pitfalls awaiting the unsuspecting registry researcher; and approaches that will give the best chance of success.

       

       0930-1000
      Panel Discussion


      HBO AND DFU PLENARY
      4:00 PM - 5:00 PM

      1600-1630
      Dirk Ubbink, MD
      "The effectiveness and costs of hyperbaric oxygen therapy for diabetic ischemic ulcers: results of the DAMOCLES multicenter trial
      "
      Ubbink image1
      This trial was conducted in 9 hyperbaric centers and 25 referring hospitals to find out whether additional HBOT would benefit patients with diabetes and ischemic leg ulcers. We randomized 120 diabetic patients with an ischemic wound to standard care without (SC) or with HBOT (SC+HBOT). Primary outcomes were limb salvage and wound healing, amputation-free survival (AFS), and direct and indirect medical costs.

           Limb salvage was achieved in 47 patients in the SC group vs. 53 patients in the SC+HBOT group. After 12 months, 28 index wounds were healed in the SC group vs. 30 in the SC+HBOT group. AFS was achieved in 41 patients in the SC group and 49 patients in the SC+HBOT group. In the SC+HBOT group 21 patients (35%) were unable to complete the HBOT-protocol as planned. Those who did had significantly fewer major amputations and higher AFS. Overall costs were slightly higher in the SC+HBOT-group.

      1630-1700
      Michael Strauss, MD
      "The Long Beach Wound Score as a Validated Tool for Comparative Effectiveness Research of Wounds and Objectifying the Indications for Hyperbaric Oxygen"
      Michael B. Strauss image
      The Long Beach Wound Score (LBWS) is a validated wound scoring system that is user-friendly, intuitively obvious and applicable for all wounds - not just diabetic foot ulcers.  Five assessments, each graded from 2-points (best possible) to 0-points using objective criteria to grade each, are summated to generate 0 to 10-point scores.
           The scores then quantify three wound categories; "Healthy" 7.5 to 10 points, "Problem" 3.5 to 7 points and "End-stage" 0 to 3 points.  The assessments include 1) Appearance of the wound base, 2) Size--including undermining, 3) Depth--to wound base or bottom of a tract, 4) Infection and 5) Perfusion.
           For wounds in the "Healthy" category only simple wound care and, occasionally, biologics are needed for management.  Deep infection, deformity, and/or ischemia are invariable present in the "Problem" wound  category.  These require debridements and antibiotics plus revascularization and/or hyperbaric oxygen (HBO2).  Juxta-wound transcutaneous oxygen measurements in room air and with HBO2 objectify when this modality is indicated for wound management. Wounds in the "End-stage" category require amputation or revascularization if salvage is indicated. The decision for amputation versus salvage in a "Transition" zone (LBWS in the 2.5 to 4 point range) require information about the patients' wellness and goals, both quantified by 0 to 10 scores as intuitively obvious and easy to use  as the LBWS.
           With 24 billion dollars a year being spent in the USA for management of chronic wounds, comparative effectiveness research (CER) is needed to evaluate the effectiveness, cost benefits, and convenience  of wound care. The essential consideration for CER is using a wound scoring system that objectifies the evaluation so "like can be compared with like."  The LBWS is the reliable (similar scores by two or more observers) and validated tool that meets this requirement. With the LBWS the UHMS has the potential to establish a registry, document the effectiveness of interventions and become the "go to" source for payers to justify authorizations for wound management including HBO2 treatments. 

      Read more

    • Saturday, June 30

      EMERGING INDICATIONS FOR HYPERBARIC OXYGEN THERAPY      
      NEW PEARLS OF WISDOM IN THE DIVING AND HYPERBARIC MEDICINE LITERATURE
      CLINICAL AND METABOLIC ASPECTS IN BREATH-HOLD DIVING



      EMERGING INDICATIONS FOR HYPERBARIC OXYGEN THERAPY PLENARY

      8:00 AM - 10:00 AM

      0800-0830
      Enrico Camporesi, MD
      "Hyperbaric Oxygen Therapy for Aseptic Necrosis of the Femoral Head andof the Femoral Condyli"

      camporesi image     Osteonecrosis of the knee (ONK) is a form of aseptic necrosis resulting from ischemia to subchondral bone tissue. Typically, common surgical treatments are invasive and palliative or time-limited. Hyperbaric oxygen (HBO2) therapy may provide a non-invasive alternative by improving oxygenation and reperfusion of ischemic areas, both for distal femoral condyli, as recently described, or for a similar malady of the femoral head, previously published.
           We recently described 37 ONK patients (29 male, 8 female; mean age ±1 SD: 54±14). 83.7% of patients presented with Aglietti stage I-II; 16.3% presented with Aglietti Stage III.  Patients were treated with HBO2 once a day, five days a week, at 2.5 ATA with 100% inspired oxygen by mask for an average of 67.9±15 sessions. Magnetic resonance imaging was performed before HBO2, within one year after completion of HBO2, and in 14 patients, 7 years after treatment. Oxford Knee Scores (OKS), an index of functionality, where 60 is normal,  were recorded before HBO2 and at the end of each HBO2 treatment cycle.
           After the 30 sessions of HBO2, 86% of patients experienced improvement in their OKS, 11% worsened, and 3% did not change. All patients improved in OKS after 50 sessions. MRI evaluation 1 year after HBO2 completion showed that edema at the femoral condyle had resolved in all but one patient. MRI at 7 year after completing therapy were all normal. In conclusion, HBO2 is beneficial in ONK. Patients experienced improvements in pain and mobility as demonstrated by improvement in OKS. Radiographic improvements were also seen upon post treatment follow-up. Aglietti staging for the entire sample saw an aggregate decrease (p < 0.01) from 1.7 ± 0.7 to 0.3 ± 0.6.


      0830-0900
      Gerardo Bosco, MD
      "Hyperbaric pre-conditioning"
      Bosco image
      Pre-conditioning (PC) has been described as the hyperbaric oxygen (HBO2) experience before a critical event, with the aim to prevent a specific clinical condition, and its development as a valuable complement both in diving medicine (Bosco, 2010) as well as prior to ischemic or inflammatory situations. PC is a preventive treatment that triggers endogenous cascades, which can protect from stress-activated and stress-reactive responses. A possible mechanism of HBO-PC mediating beneficial effects has been described as attenuation of the production of proinflammatory cytokines in response to an inflammatory stimulus such as surgery and modulation of the immune response. HBO-PC protocols are performed at 2.0–2.5 atmospheres absolute (ATA), and usually only applied for one or a few days. The physical adaptations in response to alterations in atmospheric oxygen appear to extend not only to survival, but also a preconditioned state.
           Similar to ischemic and stress preconditioning, many different paradigms have been used to demonstrate that either rapid or delayed tolerance is affected by the HBO2 therapy. Irrespective of the cause of injury, inflammatory cytokines released after the primary event trigger leukocyte activation and free radical release, causing secondary damage and extension of injury. Thus, modulating inflammatory molecules has the potential benefit of limiting leukocyte-mediated extension of injury. Many studies demonstrated a protective mechanism of HBO-PC in the injured brain, heart, or liver. Previous data by Yang and colleagues on animals demonstrated that HBO2 inhibits TNF-α production during intestinal, brain and muscle ischemia-reperfusion and it has a beneficial effect, mediated by decreased production of IL-6, IL-1β, dopamine and lactate (Bosco, 2007; Yang, 2001;2006;2010). Studies on animals showed that HBO-PC can protect the brain from ischemia-reperfusion injury and that Sirt1 is a potential molecular target for therapeutic approaches (Ding, 2017). In man, HBO-PC induces endogenous cardioprotection subsequent to ischemic reperfusion injury (Allen, 2014).
           Additionally, clinical HBO-PC showed effects before surgery. A single preoperative hyperbaric oxygen treatment on the day before surgery may reduce the complication rate in pancreatic resection (Bosco, 2014). In liver surgery, studies demonstrated to increase the number of new cells and the density of microcirculation in the regenerating liver after HBO-PC (Theodoraki, 2011). Furthermore, hyperbaric oxygen preconditioning improves postoperative dysfunctions by reducing oxidant stress and inflammation (Gao, 2017). A recent experimental paper has identified an important mechanism involved in triggering the beneficial effect of HBO-PC, as the intracellular induction of heme-oxygenase-1 in hepatic IR injury. Moreover, in dive medicine HBO-PC reduced bubble formation and platelets activation; HBO-PC might enhance lymphocyte antioxidant activity and reduce reactive oxygen species levels. Pre-breathing oxygen in water may also preserve calcium homeostasis, suggesting a protective role in the physiological lymphocyte cell functions (Bosco, 2010; Morabito, 2011).

           Whether the various preconditioning protocols contribute to the different results should be investigated in further studies and applied to diverse surgical procedures, especially major surgeries leading to postoperative ICU admission. Therefore, HBO-PC is an encouraging and feasible therapeutic strategy for protecting organs from the subsequent lethal stimulus.
      References
      1. Ding P, Ren D, He S, He M, et al (2017). Sirt1 mediates improvement in cognitive defects induced by focal cerebral ischemia following hyperbaric oxygen preconditioning in rats. Physiological research, 66(6).
      2. Yang ZJ, Bosco G, Montante A, Ou XL and Camporesi EM (2001) Hyperbaric O2 reduces intestinal ischemia-reperfusion-induced TNF-a production and lung neutrophil sequestration. Eur J Appl Physiol 85: 96-103
      3. Yang Z, Nandi J, Wang G, Bosco G, et al. (2006) Hyperbaric Oxygenation ameliorates indomethacin-induced enteropaty in rats by modulating TNF-a and IL-1 b production. Dig Dis Sci 34(1-2):70-6.
      4. Bosco G, Zj Yang, J Nandi, Jp Wang, et al. (2007) Effects of hyperbaric oxygen on glucose, lactate, glycerol and antioxidant enzymes in the skeletal muscle of rats during ischemia and reperfusion. Clin Exp Pharmacol Physiol 34, 70-76.
      5. Yang Zj, Bosco G, Xie Y, Chen Y, Camporesi EM. (2010) Hyperbaric oxygenation alleviates MCAO-induced brain injury and reduces hydroxyl radical formation and glutamate release. Eur J Appl Physiol. Feb;108(3):513-22.
      6. Bosco G, Yang Zj, Di Tano G, Camporesi EM, et al. (2010) Effect of in-water versus normobaric oxygen pre-breathing on decompression-induced bubble formation and platelet activation. J Appl Physiol. May;108(5):1077-83.
      7. Morabito C, Bosco G, Pilla R, Corona C, et al. (2011) Effect of pre-breathing oxygen at different depth on oxydative status and calcium concentration in lymphocytes of scuba divers. Acta Physiol (Oxf). May;202(1):69-78.
      1. Bosco G, Casarotto A, Nasole E, Camporesi E, et al. (2014). Preconditioning with hyperbaric oxygen in pancreaticoduodenectomy: a randomized double-blind pilot study. Anticancer research, 34(6), 2899-2906.
      2. Theodoraki K, Tympa A, Karmaniolou I, Tsaroucha A, et al. (2011). Ischemia/reperfusion injury in liver resection: a review of preconditioning methods. Surgery Today, 41(5), 620.
      3. Gao Z. X, Rao J, & Li Y. H. (2017). Hyperbaric oxygen preconditioning improves postoperative cognitive dysfunction by reducing oxidant stress and inflammation. Neural regeneration research, 12(2), 329.
      4. Allen M, Golembe E, Gorenstein S, Butler G. Protective effects of hyperbaric oxygen therapy (HBO2) in cardiac care-A proposal to conduct a study into the effects of hyperbaric pre-conditioning in elective coronary artery bypass graft surgery (CABG) Undersea Hyperb Med. 2014;42:107–114.


      0900-0930
      Shai Efrati, MD
      "Brain injury"

      efratiObjectives:

      1. Basics pathophysiological cascade of non-recoverable brain injuries.
      2. The neuroplasticity effect of hyperbaric oxygen therapy
      3. Selecting the optimal candidate for the treatment

      Clinical studies published in recent years present convincing evidences that hyperbaric oxygen (HBO2) therapy can be the coveted neurotherapeutic method for brain repair of neurological incidents like traumatic brain injury and stroke. This new understanding leads to a paradigm change in the way that we refer to chronic brain injuries; from now these should be thought of like other non-healing wounds in other parts of the body.
           The classical candidate for HBO2 is a patient with unrecovered brain injury where tissue hypoxia is the limiting factor for the regeneration process. In this patient, HBO2 may induce neuroplasticity in the stunned regions where there is a brain anatomy/physiology mismatch (as for example PET/MRI).
           In this lecture we will discuss the multifaceted role HBO2 can play in neurotherapeutics based on recent persuasive evidence demonstrating HBO2 efficacy in brain repair as well as a new understanding of brain energy management and response to brain damage. We will also discuss how to select suitable candidates and how to choose the optimal HBO2 protocol for the selected candidate.


      0930-1000
      Panel Discussion


      NEW PEARLS OF WISDOM IN THE DIVING AND HYPERBARIC MEDICINE LITERATURE PLENARY
      1:00 PM - 2:00 PM

      1300-1330
      Brian Keuski, MD; Fellow, Duke Hyperbarics
      "Diving medicine literature update"

      headshot Keuski

      Take a whirlwind tour through the last 12 months of diving medicine literature. Major topics include: decompression illness, fitness to dive issues, immersion pulmonary edema, and diving physiology.



      1330-1400
      Lince Varughese, MD; Fellow, LSU Hyperbarics
      "Hyperbaric medicine literature update"

      Lince Varughese MD

      Dr. Varughese will give a brief update on key articles in recent hyperbaric medicine literature; novel ideas and newfound wisdom.



      CLINICAL AND METABOLIC ASPECTS IN BREATH-HOLD DIVING PLENARY
      4:00 PM - 5:00 PM

      1600-1620
      Gerardo Bosco, MD
      "Adaptive mechanisms in breath-hold divers"

      Bosco imageThe human body faces extreme physiological challenges while immersed with voluntary breath-holding. Breath-hold diving is potentially associated to extreme environmental factors such as increased hydrostatic pressure, hypoxia, hypercapnia, hypothermia and strenuous exercise. Physiological adaptations can depend among the time of breath suspension and the depth of diving. While descending chest squeeze and blood redistribution occur. Indeed, blood as being an incompressible fluid from peripheral circulation is shifted to the chest. The intrathoracic blood volume increases. Moreover, face immersion results in induced bradycardia, due to the diving reflex. Conversely, breath-holding at rest, out of water, induces non-significant changes in heart rate. Breath-hold swimming, even on the surface, instead causes pronounced bradycardia. During deep diving a higher O2 consumption and a fall in alveolar and blood O2 content was observed. Consequently, alveolar CO2 pressure increases due to chest compression while descending.
           It was supposed that the maximum reachable depth in breath-hold diving was determined by the relationship between total lung capacity and residual volume. Craig suggested a compensatory physiologic mechanism to explain why thoracic implosion does not occur and hypothesized that a certain amount of blood was diverted from the peripheral circulation into the chest. Intrathoracic pressure in such a condition represented the elastic behavior of the chest wall when exposed to high hydrostatic pressure. The increased hydrostatic pressure at depth reduces pulmonary gas volumes and consequently increases intrathoracic blood volume, with enlargement of the right heart chambers and pressures. On the contrary, the left sections of the heart do not undergo any enlargement, and do not show any sign of pressure increase. The systolic stroke volume is the consequence of Starling’s law: the blood shift stretches the heart and increases the intracardiac volume. This certainly means that, although rarely exploited in nature, anaerobic metabolic reserve represents a resource for survival of the animal. The same can be said for high-altitude hypoxic environments.
           Another consideration is the “graded response” to breath-hold diving in relation to the level of physiological stress and to the control by the central nervous system. The diving response is a strategic adaptation to hostile environmental conditions common to many animals but human breath-hold divers require knowledge for the safe and health of participants. 

      1620-1640
      Peter Lindholm, MD
      "Pulmonary pathophysiology in deep breath-hold diving"
      lindholm image

      Deep breath-hold diving may expose the lungs to the limits of known human physiology. We will discuss barotrauma of descent with pulmonary edema, glossopharyngeal hyperinsufflation and arterial gas embolism.

      1640-1700
       Alessandro Marroni, MD
      "Breaking news on breath-hold diving research"
      A.Marroni VHQ small


      Recent data from field research on pathophysiology of breath-hold diving will be presented, with a particular focus on breath-hold diving-induced pulmonary edema, Taravana, epidemiology, mechanisms, pathogenetic hypotheses and data on genetic predisposing factors.


       

       

      Read more

    Read more

  • Continuing Education Credits: Annual Meeting

    In order to receive continuing education for the UHMS ASM you must complete and submit an evaluation.

    Accreditation Statement:  
    The Undersea and Hyperbaric Medical Society is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    Designation Statements: 
    The Undersea and Hyperbaric Medical Society designates this live activity for a maximum of 21 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Nursing CEU is approved by the Florida Board of Registered Nursing Provider #50-10881. ASM Credit hours 21.
    Licenses Types Approved:

    • Advanced Registered Nurse Practitioner
    • Clinical Nurse Specialist
    • Licensed Practical Nurse
    • Registered Nurse
    • Certified Nursing Assistant
    • Respiratory Care Practitioner Critical Care
    • Respiratory Care Practitioner Non-Critical Care
    • Registered Respiratory Therapist
    • Certified Respiratory Therapist

    NBDHMT: This live activity is approved for 21 Category A credit hours by National Board of Diving and Hyperbaric Medical Technology, 9 Medical Park, Suite 330, Columbia, South Carolina 29203.

    Full Disclosure Statement:
     All faculty members and planners participating in continuing medical education activities sponsored by Undersea and Hyperbaric Medical Society are expected to disclose to the participants any relevant financial relationships with commercial interests. Full disclosure of faculty and planner relevant financial relationships will be made at the activity.

    Disclaimer: The information provided at this CME activity is for Continuing Medical Education purposes only.  The lecture content, statements or opinions expressed however, do not necessarily represent those of the Undersea and Hyperbaric Medical Society

     

    MAINTENANCE OF CERTIFICATION (MOC):

    “MOC ABPM: This activity has been approved by the American Board of Preventive Medicine for up to TBD MOC credits. Claiming ABPM MOC credit is appropriate for those who are ABPM diplomates.”

    Read more

  • Social Events

     

    WEDNESDAY, JUNE 27

    WELCOME RECEPTION
    7:00 pm - 9:00 pm
    Casita Courtyard

    THURSDAY, JUNE 29

    EXHIBITORS WINE & CHEESE RECEPTION
    6:00 pm - 7:00 pm
    Exhibit Hall (Fiesta 6)

    SATURDAY, JUNE 30

    ANNUAL AWARDS BANQUET (additional fees for banquet and after party)
      Banquet Reception: 7:00 pm - 7:30 pm
      Dinner: 7:30 pm - 10:00 pm (Fiesta 5)
      After Party: 10:00pm - 12am  (Monterrey & La Mesa Patio)

    Read more

  • Committee Meeting Schedule

    SUBJECT TO CHANGE
    posted 3-6-18

    Please contact lisa@uhms.org to schedule

    EVENT

    START TIME

    END TIME

    LOCATION

    TUESDAY, JUNE 26

    UHMS Board of Directors Meeting (Private Meeting)

    4:00 PM

    11:00 PM

    Sierra 2

    WEDNESDAY, JUNE 27          

    ABPM Exam

    1:00 PM

    4:00 PM

    Fiesta 1

    CHT/CHRN Study Hall

    1:00 PM

    3:00 PM

    Fiesta 3

    CHT/CHRN Exam

    3:30 PM

    5:30 PM

    Fiesta 3

    Editorial Board Meeting

    3:00 PM

    5:00 PM

    Fiesta 2

    HBO Therapy Committee Meeting

    4:45 PM

    7:45 PM

    Fiesta 1

    Associate's Council Meeting

    5:30 PM

    7:30 PM

    Fiesta 2

    THURSDAY, JUNE 28

    Safety Committee Meeting

    7:00 AM

    8:00 AM

    Fiesta 2

    Specialty ED & QUARC Team Meeting (Marc Robins)

    10:00 AM

    12:00 AM

    Fiesta 1

    Accreditation Council Meeting

    10:00 AM

    12:00 PM

    Fiesta 2

    ACEP UHM Section Meeting

    10:00 AM

    11:00 AM

    Fiesta 3

    GME Committee Meeting

    11:00 AM

    12:00 PM

    Fiesta 3

    Material Testing Advisory (AD HOC) Committee

    2:00 PM

    3:30 PM

    Fiesta 1

    Education Committee Meeting

    5:00 PM

    6:00 PM

    Fiesta 1

    BNA Board Meeting

    5:00 PM

    6:00 PM

    Fiesta 3

    FRIDAY, JUNE 29

    PAST PRESIDENT'S BREAKFAST

    7:00 AM

    8:00 AM

    Fiesta 3

    NBDHMT Breakfast

    7:00 AM

    8:00 AM

    Fiesta 2

    NBDHMT Board Meeting

    8:00 AM

    12:00 PM

    Fiesta 1

    ECCHO Working Group Meeting

    10:00 AM

    11:00 AM

    Fiesta 2

    Publication Committee Meeting

    10:00 AM

    11:00 AM

    Fiesta 3

    ACHM-UHMS Meeting

    11:00 AM

    1:00 PM

    Fiesta 2

    Registry Meeting (Buckey)

    11:30 AM

    12:30 AM

    Fiesta 3

    QUARC Committee Meeting

    2:00 PM

    3:00 PM

    Fiesta 2

    BNA General Meeting

    3:00 PM

    4:00 PM

    Fiesta 1

    Research Committee Meeting

    3:00 PM

    4:00 PM

    Fiesta 2

    UHMS Business Meeting - Open meeting

    5:30 PM

    6:30 PM

    Fiesta 5

    Specialty Council Meeting (Toups) PRIVATE Meeting

    5:30 PM

    7:30 PM

    Fiesta 1

    SATURDAY, JUNE 30

    Chapter President's Committee Meeting

    10:00 AM

    11:00 PM

    Fiesta 1

    Diving Committee Meeting

    10:00 AM

    12:00 PM

    Fiesta 3

    Membership Committee Meeting

    11:00 AM

    12:00 PM

    Fiesta 1

    Read more